Nanoscale platform to study unstructured proteins interactions by Corvaglia, Stefania
 
 
  UNIVERSITÀ’ DEGLI STUDI DI TRIESTE 
 
  
 XXVI CICLO DEL DOTTORATO DI RICERCA IN 
 
NANOTECNOLOGIE  
  
 
 
 
NANOSCALE PLATFORM TO STUDY 
UNSTRUCTURED PROTEINS INTERACTIONS. 
 
 
Settore scientifico-disciplinare:  FIS/03  
      
DOTTORANDO / A  
STEFANIA CORVAGLIA  
  
COORDINATORE  
PROF.SSA LUCIA PASQUATO  
 
SUPERVISORI DI TESI 
DOTT.SSA LOREDANA CASALIS  
 
DOTT. DENIS SCAINI  
 
 
 
 
 
ANNO ACCADEMICO 2012 / 2013  
       
   
1 
 
Contents 
 
Riassunto ........................................................................................................................ 3 
Abstract .......................................................................................................................... 5 
1. Intrinsically disordered proteins: α-synuclein ........................................................ 7 
1.1 Protein folding, misfolding and aggregation ............................................................. 7 
1.1.1 The fundamental mechanism of protein folding ............................................ 7 
1.1.2 Protein folding and misfolding in cells .......................................................... 8 
1.1.3 Protein aggregation and amyloidosis ........................................................... 10 
1.2 Parkinson’s disease ................................................................................................. 11 
1.2.1 Genetics of PD ............................................................................................. 14 
1.3 Alpha-synuclein ...................................................................................................... 15 
1.3.1 AS interaction with membranes ................................................................... 17 
1.3.2 The aggregation process ............................................................................... 21 
1.3.3 AS-DA interaction ........................................................................................ 25 
2. Proteins at solid interface ....................................................................................... 28 
2.1 Atomic force microscopy ........................................................................................ 29 
2.1.1 Static mode: Contact mode (CM) ................................................................. 31 
2.1.2 Dynamic mode: Non-Contact and Tapping mode ........................................ 33 
2.1.2.1 Force-modulation microscopy (FMM) ...................................................... 34 
2.2 AFM nanolithography: nanografting ...................................................................... 36 
2.3 Immobilization strategies ........................................................................................ 41 
2.3.1 Non-covalent adsorption .............................................................................. 41 
2.3.2 Covalent binding of proteins ........................................................................ 42 
2.3.2.1 Cysteine-tag ............................................................................................... 42 
2.3.2.2 Amine-coupling ......................................................................................... 42 
2.3.3 Bioaffinity interactions ................................................................................. 43 
2.3.3.1 Histidine-NTA ........................................................................................... 43 
2.3.3.2 DNA-Directed protein Immobilization (DDI) ........................................... 44 
2.4 AFM nanografting: a potential tool for the study of IDPs ...................................... 45 
3. Proteins at model membranes ................................................................................ 48 
   
2 
 
3.1 Membrane composition and phase separation ........................................................ 48 
3.1.1 Lipid rafts ..................................................................................................... 51 
3.1.2 Lipid rafts and disease .................................................................................. 53 
3.2 Artificial lipid bilayers ............................................................................................ 53 
3.2.1 Artificial Lipid bilayers: a model for lipid rafts ........................................... 59 
4. Results: AS immobilization on a gold surface ...................................................... 61 
4.1 via cysteine-tag  ............................................................................................... 61 
4.1.2 AS-DA affinity ............................................................................................. 66 
4.1.2.1 AS nanostructures to study DA-AS affinity .............................................. 66 
4.1.2.2 mAb-DA non-competitive binding............................................................ 69 
4.1.1 AS nanostructures to promote the formation of supramolecular assembly and 
to study the effect of DA on them. ............................................................................ 71 
4.2 Other strategies for AS immobilization .................................................................. 74 
4.2.1 Via NTA-Ni-Histidine chemistry ................................................................. 74 
4.2.2 Amine-coupling ............................................................................................ 79 
4.3 Discussion and conclusions .................................................................................... 81 
5. Results: supported lipid bilayers, a method to study AS interactions  ............... 84 
5.1 Supported lipid bilayers: characterization ............................................................... 86 
5.1.1 Method of deposition.................................................................................... 86 
5.1.2 Role of water ................................................................................................ 88 
5.1.3 Role of cholesterol........................................................................................ 91 
5.1.4 AFM characterization in liquid .................................................................... 95 
5.1.5 GISAXS measurements and humidity-cholesterol effect ............................. 96 
5.2 AS-lipid membrane interactions ........................................................................... 104 
5.2.1 AFM-characterization ................................................................................ 104 
5.2.2 GISAXS measurements .............................................................................. 112 
5.3 Discussion and conclusions .................................................................................. 113 
6. Materials and methods ......................................................................................... 117 
Appendix .................................................................................................................... 123 
Bibliography .............................................................................................................. 134 
 
 
   
3 
 
Riassunto 
 
Le proteine intrinsecamente disordinate (IDP), nello stato nativo non ripiegate, 
sono inclini all’aggregazione e direttamente correlate con lo sviluppo di 
malattie amiloidi. Tra queste, ci siamo focalizzati sullo studio dell’alfa-
Sinucleina (AS), una proteina coinvolta nella malattia di Parkinson, un disturbo 
neurodegenerativo caratterizzato dalla degenerazione dei neuroni dopaminergici 
e l’accumulo di AS in placche amiloidi. Sebbene lo studio delle interazioni AS-
dopamina sia di importanza cruciale nella comprensione dei meccanismi 
responsabili dello sviluppo della malattia, tuttavia, non sono disponibili dati in 
letteratura riguardo all’affinità di questo legame nei diversi stati 
ripiegati/funzionali dell’AS. L’elevata tendenza all’aggregazione delle IDP 
rende difficile il loro studio in soluzione e anche una stima approssimativa dei 
parametri relativi all’affinità di legame è estremamente difficile. Nuove 
tecniche di superficie potrebbero pertanto permettere lo studio delle interazioni 
di legame di molecole e di farmaci capaci di favorire/inibire l’aggregazione. In 
particolare, le tecniche di superficie potrebbero permettere un migliore 
controllo dell’immobilizzazione di queste proteine, particolarmente instabili in 
soluzione, e di studiare con alta precisione fenomeni di legame. 
Con questa visione, la microscopia di forza atomica (AFM) rappresenta 
un’opportunità. Il nanografting, una tecnica litografica per mezzo AFM, 
permette l’immobilizzazione di proteine orientate con il preciso controllo dei 
parametri di immobilizzazione. Con AFM e AFM-nanografting, abbiamo 
prodotto una nuova piattaforma per lo studio di diversi aspetti 
dell’aggregazione/interazione dell’AS. Abbiamo quindi studiato l’affinità di 
legame tra AS e dopamina misurando variazioni nell’altezza e nella rugosità 
della topografia AFM su AS immobilizzata in aree confinate, in funzione della 
concentrazione di dopamina. Il valore micromolare della costante di 
dissociazione (Kd) è stato inoltre confermato dallo studio dello spiazzamento di 
un anticorpo legato all’AS in seguito all’aggiunta di dopamina. Sebbene la Kd 
calcolata con il nostro approccio sia una stima della reale Kd calcolata in 
soluzione, in quanto influenzata dall’affollamento delle molecole o ai limiti di 
diffusione, i nostri risultati sono comunque degni di nota. 
Infine, abbiamo testato il nostro saggio per lo studio delle fasi preliminari 
dell’aggregazione dell’AS. In particolare, abbiamo osservato come aggregati 
confinati di AS siano disciolti dall’azione della dopamina, confermando il suo 
ruolo nell’inibizione della fibrillazione. In questo modo, abbiamo creato un 
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saggio potenzialmente utilizzabile per lo screening di nuove molecole che 
interagiscono con l’AS ed eventualmente utilizzabili come farmaci. 
Inoltre, l’interazione di AS con microdomini della membrana cellulare (lipid 
rafts) sono oggetto di dibattito. Per questo motivo, abbiamo utilizzato dei doppi 
strati lipidici modello con composizione capace di mimare quella dei lipid rafts. 
In particolare, abbiamo caratterizzato con AFM e GISAXS (Grazing Incidence 
Small Angle X-ray Scattering) delle membrane lipidiche di tre componenti, 
aventi separazione di fase lipidica, studiando l’effetto dell’umidità e della 
percentuale di colesterolo su ciascuna fase. Abbiamo quindi studiato l’effetto 
del legame dell’AS su questo sistema modello. In particolare, immagini di 
topografia AFM in liquido ci hanno dato la possibilità di discriminare la 
topografia di strutture filamentose formatesi inseguito all’interazione di AS. Il 
fenomeno, dipendente dalla fase lipidica della membrana e quindi dall’ordine 
delle molecole, sembra essere favorito da un blando impacchettamento dei 
lipidi. Inoltre, utilizzando misure GISAXS, è stato possibile determinare un 
considerevole riordinamento della membrana in seguito al legame di AS.  
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Abstract 
 
Intrinsically disordered proteins (IDPs) are natively unfolded, prone to 
aggregation and directly correlated with amyloid diseases. Among them, we 
focused on alpha-Synuclein (AS), a protein related to Parkinson’s disease, a 
neurogenerative disorder characterized by the degeneration of dopaminergic 
neurons and the accumulation of AS into amyloid plaques. In particular, the 
study of AS-dopamine (DA) adducts is crucial for the comprehension of the 
mechanisms responsible of Parkinson’s disease development. However, 
according to our knowledge, there is no evidence in literature about AS-DA 
binding parameters at different folding/functional state of AS. IDPs have in fact 
a strong propensity to aggregate, making it extremely difficult to get even rough 
estimation of binding affinities in solution. Therefore, new methods able to 
study surface immobilized IDPs could be useful for both fundamental studies of 
binding interactions and drug screening of new compounds able to interact 
favouring/inhibiting the aggregation process. In particular, the use of a surface-
based technique could help to better control the immobilization of such 
proteins, particularly unstable in solution, and to study with high precision 
binding events.  
With this perspective, atomic force microscopy (AFM) offers a challenge. 
Nanografting, an AFM mediated nanolithographic technique, allows for the 
nanoscale immobilization of proteins in a well-oriented manner with the precise 
control of the immobilization parameters. By means of AFM and AFM-
nanografting, we produced a new platform able to study different aspects of AS 
aggregation/interactions. First, we studied AS-dopamine binding affinity by 
measuring the variation of AFM topographic height on AS nanopatches due to 
binding of DA on the patch as a function of its concentration in solution, and 
the correspondent surface roughness variation. The value of the dissociation 
constant, in the micromolar range, was confirmed by studying the displacement 
of AS-bound mAbs, after the addition of dopamine. We think that this result is 
noteworthy, even though we are aware that the Kd values obtained with our 
assay are probably a very rough estimate of the Kd of the AS/DA interaction 
occurring in solution, due for instance to AS surface crowding and restrictions 
to diffusion.  
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Finally, the assay was used to study the early stages of the aggregation process. 
In particular, dopamine dissolved confined AS aggregates confirming its role in 
the inhibition of fibrillation. In this way, we created a potential screening assay 
able to study the interaction of AS with new molecules virtually usable as new 
drugs.  
Moreover, the interaction of AS with lipid rafts, specialized microdomains of 
the cell membrane, is object of a strong debate. For this reason, we created a 
model supported lipid bilayer with composition able to mimic lipid rafts. In 
particular, we characterized by both AFM and Grazing Incidence Small Angle 
X-ray Scattering (GISAXS) a three components membrane presenting a lipid 
phase separation, focusing on the effect of humidity and cholesterol percentage 
on the structure of each phase. Then, we studied the effect of AS binding on 
this membrane model system. In particular, trough AFM imaging in liquid we 
discriminated the topology of filamentous structures resulting from AS binding. 
The phenomenon is dependent on the membrane’s lipid phase and order and is 
favoured by mild packing of lipids. From GISAXS measurements, the 
occurrence of a strong rearrangement of the membrane upon AS binding was 
suggested. 
   
7 
 
1. Intrinsically disordered proteins: α-synuclein 
 
1.1 Protein folding, misfolding and aggregation 
 
One of the most fascinating characteristic of the living cell is the ability of auto-
assembly in a precise and functional manner. The folding of the protein in the 
three dimensional conformation is one of the most fundamental example of 
biological self-assembly and contribute to the correct functions of the cell. After 
water, proteins are the most abundant component of the cell. The proper three-
dimensional configuration of the protein gives stability to the molecules and is 
fundamental for correct protein activity as in cell trafficking, regulation of cell 
growth and differentiation. It can happen that protein folding does not occur in 
a proper way and it is probably the starting point for a cascade that leads to 
pathological conditions 1,2. 
 
1.1.1 The fundamental mechanism of protein folding 
 
The specific three-dimensional conformation of a polypeptide chain is still 
unclear in many aspects. The total number of the possible conformations of a 
polypeptide is huge but usually the native folded state of a protein is the most 
thermodynamically stable in physiological conditions 3. The folding mechanism 
does not require mandatory intermediate folding steps but incompletely folded 
polypeptides, during inherent fluctuations, enable residues in various chain 
position to come in contact. In this way, the native, more stable protein form is 
selected. From here, the concept of an energy landscape was developed, in 
which the free energy of the polypeptide as a function of the protein 
configuration is described. During the folding process, a decrease of the free 
energy is observed (Fig. 1.1). The early stages of the folding process were 
studied on small proteins (less than 100 residues) and analysing the 
intermediate folding stages, a nucleation-condensation process has been 
suggested, in which the formation of a folding nucleus is the starting point for 
the following condensation (Fig. 1.1). 
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Figure 1.1. Schematic representation of the free energy landscape of protein folding. 
Example of a computer simulation performed on acylphosphatase 4.  The critical step is the 
formation of an intermediate conformation (saddle point of the energy funnel). The yellow part 
of the transition state represent three key residues involved in the formation of the structure. 
Once these contacts occurred, the native-like fold is established. Adapted from Dobson, 2003 1 
 
Moreover, integration of computer simulation of limited region of the protein 
with experimental observation suggested that intermediate folding state, despite 
the high rate of disorder, is characterized by topology very similar to that of the 
native state. In other words, the early interaction between a small number of 
key residues (especially between hydrophobic and polar residues) force the 
protein to adopt a certain structure, similar to the native three-dimensional 
conformation 4,5. In the final stages of the folding, the native structure is almost 
invariable. Probably, the transition state works as a “quality control” for the 
folding, in fact if these interactions do not occur, the protein does not assume 
the correct topology and does not arrange in a stable globular structure 6. 
 
1.1.2 Protein folding and misfolding in cells 
 
The genetic information for the synthesis of a protein is carried out by the DNA 
sequence responsible for the codification of the proteins. The synthesis occurs 
in the ribosome and brings to the formation of the amino acidic chain. In vivo, 
the folding of the protein is usually co-translational, i.e. it occurs usually during 
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the synthesis of the polypeptide, while the chain is still attached to the 
ribosome. In some other cases, the folding happens in the cytosolic space, after 
the release from the ribosome, whereas sometimes it happens in other 
compartments such as the endoplasmatic reticulum (ER). Incompletely folded 
proteins, exposing regions normally hidden in the native state (e.g. hydrophobic 
core, highly prone to the aggregation), can interact aspecifically with other 
molecules in the crowded environment of the cell. For this reason, the cell uses 
a strategy to prevent this behaviour using molecular chaperones that bind and 
guide the folding of the polypeptide. These chaperones recognize and bind 
hydrophobic regions and unstructured protein chains promoting the correct 
folding by cyclic binding and release of the substrate 7. Some chaperones are 
able not only to protect nascent proteins, but also, interacting with misfolded or 
solubilizing aggregated proteins, can give them the possibility to refold 
correctly. The expression of some chaperones increases in high stress condition 
for the cell (e.g. heat shock proteins, Hsp family, highly expressed after 
temperature increase), where some native proteins are unfolded 7. 
In the eukaryotic cell, many proteins are secreted in the extracellular 
environment.  
 
Figure 1.2. Regulation of protein folding in ER. Some proteins, synthetized on the ribosome, 
are translocated in the ER where the folding occurs. Correctly folded proteins are addressed to 
the Golgi apparatus for the secretion in the extracellular space, while misfolded ones are 
identified by the quality control, ubiquitinated and addressed to the proteasome where they are 
degraded. Adapted from Dobson, 20031 
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In this case, the folding occurs in the endoplasmic reticulum (ER) and then they 
are addressed to the Golgi apparatus for the secretion. The ER is highly 
enriched in chaperones for enhancing the correct protein folding. Moreover, 
here proteins have to overcome a quality control that involves a series of 
glycosylation and deglycosylation reactions that permit to distinguish between a 
folded and a misfolded protein. According to that signal, the major part of the 
folded proteins are addressed to the endoplasmic reticulum (ER) and Golgi 
apparatus for the secretion, while misfolded ones are recognized and addressed 
to the ubiquitine-proteasome system where they are degraded (Fig. 1.2). 
Whether the cell machinery devolved in misfolded protein elimination is 
lacking, proteins fail to fold correctly cannot work properly and give rise to 
pathological conditions, some of them summarized in table 1. Some of these 
diseases are due to alterations in the function of the protein (e.g cystic fibrosis), 
in some others the misfolded protein starts to aggregate in the cytosolic or 
extracellular space of patients with amyloid disease (e.g. Alzheimer and 
Parkinson’s diseases) 2. 
 
Table 1.1. The table reports protein folding alteration, the site of folding and related diseases. 
 
1.1.3 Protein aggregation and amyloidosis 
 
During the last decade, the interest in the study of amyloid diseases increased 
tremendously and the number of discovered protein with little or no ordered 
structure was growing exponentially. This class of proteins was defined for the 
first time as “natively unfolded” in 1994 8. Regarding amyloid proteins, their 
soluble forms are usually very different but a certain relation between the amino 
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acidic chain sequence and the propensity of the protein to be “natively 
unfolded” has been observed. In particular, the presence of a net charge at 
physiological pH (often negative) and a low content of hydrophobic amino 
acids has been noted for several “natively unfolded” proteins 9. 
The deposits found in patients with amyloid pathologies have in common many 
aspects. It was observed in fact, that in all of these cases there is the presence of 
amyloid fibrils composed by copies of the same protein. These fibrils are long 
(>1 µm), thin (10-20 nm), straight and unbranching. The protein, in these three-
dimensional aggregates, is organized in β-sheet conformation, perpendicular to 
the main axis of the fibril 10. Amyloid fibrils (either ex vivo or in vitro) are 
hystorically defined by three main criteria: green birefringence upon staining 
with Congo Red, fibrillar morphology, and β-sheet secondary structure. 
Moreover, amyloid fibrils were widely studied by the use of fluorescent 
intercalating agents as Thioflavin T to study fibrils both in tissue samples and 
other in vitro studies 11,12. 
 
1.2 Parkinson’s disease 
 
Parkinson’s disease (PD) is one of the most common neurodegerative disease 
and affects 1-2% of the population over 65 years 13. James Parkinson in the 
classic monograph “An essay on the shaking palsy” 14 described for the first 
time in 1817 six patients suffering of the movement disorders which came to 
bear his name. Clinically, it is characterized by three cardinal symptoms: 
muscle rigidity, bradykinesia and resting tremor. In addition, postural 
instability, a mask-like facial expression and festinating gait are often observed. 
Cognitive impairment is present in a significant proportion of patients at 
advanced stages of the disease. Although the pathological features were well 
described, the molecular mechanisms were obscure and it was considered 
initially a neuropsychiatric disorder. Neurologically, the pathology is 
characterized by the substantial loss of dopaminergic neurons in the substantia 
nigra pars compacta, the area of the brain involved in the activation of the 
movement (Fig. 1.3). The early symptoms appear after the death of the 70% of 
the dopaminergic neurons 15 which are less than 1% of the total number of brain 
neurons but, depending on the brain regions that they innervate, are 
fundamental for motor behaviour, motivation and working memory 16. 
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Figure 1.3. Schematic representation of Substantia nigra pars compacta. Parkinson’s disease 
is characterized by alterations in this region of the brain. The loss of dopaminergic neurons is 
evident in post-mortem brains of PD patients as a depigmentation of this area.  
In 1992 Lewy described for the first time the inclusions characteristic of PD, 
called Lewy bodies (Fig. 1.4). These eosinophilic, round cytoplasmic plaques 
are composed by fibrillaceus inclusions of α-Synuclein (AS) and are confined 
largely to nerve cells, with glial cells being only rarely affected 17.  
 
Figure 1.4. Substantia nigra from patients with PD immunostained for AS. a. Two 
pigmented nerve cells, each containing an AS-positive Lewy body (thin arrows). Lewy neurites 
(thick arrows) are also immunopositive. Scale bar, 20 µm. b. A pigmented nerve cell with two 
AS -positive Lewy bodies. Scale bar, 8 µm. c. AS positive, extracellular Lewy body. Scale bar, 
4 µm. From Goedert, 2001 18 
   
13 
 
Transgenic model animals, expressing high levels of human wild-type or mutant 
AS, show the formation of lesions very similar to those found in PD patients, 
providing evidence of the central role of AS deposits in the pathogenesis of PD 
19–22. In the late 1950s it was identified the presence of dopamine (DA) in the 
mammalian brain 23,24. The high concentration of DA in the striatum was 
compatible with its role as neurotransmitter 25,26. Carlsson demonstrated a 
strategic role of DA in the control of the motor function and suggested that a 
deficiency in the DA level could be fundamental for the development of PD. He 
showed that L-dihydroxyphenylalanine (L-DOPA), a precursor of DA (Fig. 
1.5), passing through the blood brain barrier, could be used to restore the DA 
brain normal level and the motor functions in animals 24,27. Despite the great 
importance of L-DOPA in the therapy of PD, its efficacy is limited. In 
particular, the major benefices are greatest during the early stages of the 
disease, while they decrease as the disease progresses. This therapy in fact is 
not able to repair the brain damages due to the nerve cell degeneration in the 
substantia nigra, but it can only reduce the symptoms associated with the 
disease. The ability to identify a therapy able to interfere with the molecular 
mechanism at the basis of the neurodegeneration requires a more fundamental 
knowledge of the causes of the disease, still obscure in many aspects. 
 
Figure 1.5. Metabolic pathway of catecholamines synthesis. L-DOPA, precursor of DA is 
converted into DA inside the brain. 
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1.2.1 Genetics of PD 
 
The 90% of the cases of PD are sporadic. The causes are unclear but a role of 
the exposure to chemicals and a toxic environment was suggested 28. The 
remaining 10% is familiar and a genetic correlation with the development of the 
disease was identified. Genetic defects, both autosomic recessive and dominant, 
were characterized. In particular, 16 PD-related loci (PARK loci) and 11 genes 
associated were described (table 1.2). Among these genes, α-synuclein (also 
known as SNCA) and leucine rich repeat kinase 2 (LRRK2) are autosomal 
dominant, while parkin, PTEN-induced putative kinase 1 (PINK1), DJ-1, are 
autosomal recessive genes. Defects in the ubiquitin carboxyl-terminal esterase 
L1 (UCHL1) gene were observed only in one case of familiar PD and its 
correlation with the disease is still unclear. The causative genes of the four 
remaining loci are not yet identified 29,30. 
 
 
Table 1.2. 16 PD-related loci are associated to 11 genes. In the table the chromosome position, 
their inheritance and the probable function is reported. From Thomas et al , 2011 30 
 
Sporadic and familiar forms of PD have many clinical and pathological aspects 
in common. For this reason, the identification of the physiological function of 
the proteins encoded by these genes is necessary in order to find a novel target 
in the treatment of PD. However, mitochondrial dysfunction, protein 
phosphorylation, oxidative stress, protein misfolding and impairment of the 
ubiquitin proteasome system (UPS) have been identified in both forms of PD. 
Studying familiar autosomal-dominant forms of PD, mutations affecting AS 
locus have been characterized. In particular, point mutations (A53T, A30P and 
E46K) 31 and multiplications (duplication and triplications) 32 were identified in 
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the AS gene as related to PD. The fact that patients with triplications are usually 
younger than ones with duplications suggests that higher level of AS is 
probably toxic for the cell 33.  
 
1.3 Alpha-synuclein 
 
The gene SNCA encodes for alpha synuclein (AS), a small protein (14.460 Da, 
140 residues) that lacks of a specific structure in the native state as reported by 
previous spectroscopic and NMR studies 34–36. It is considered an Intrinsically 
Disordered Protein (IDP) and a naturally unfolded protein at physiological 
conditions. This characteristic is presumably due to the aminoacidic 
composition of the protein that has an high negative charge at neutral pH and 
low hydrophobicity 9.  
 
 
Figure 1.6. Primary structure of AS. The scheme on top shows the three main domains of AS. 
The N-terminal (red) is an amphipathic domain, the central region (green) is a highly 
hydrophobic domain known as non amyloidogenic component of the extracellular senile plaque 
(NAC), which promotes the protein aggregation. The C-terminal domain (blue) has an acidic 
character. The scheme at the bottom reports the aminoacidic AS sequence.  Basic amino acid 
are coloured in blue, acidic ones are red. 
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The primary sequence of the protein can be divided into three main regions 
(Fig. 1.6): 
 residues 1-60 that contains imperfect repetitions of 11 residues with a 
highly conservative hexamer motif (KTKEGV). It is the N-terminal 
region and is predicted to form amphipathic α-helices, typical of the 
lipid-binding domain of apolipoproteins 37,38; 
 residues 61-95, known as non-amyloid β-component (NAC region) with 
high propensity to the aggregation. It contains two additional KTKEGV 
repeats; 
 residues 96-140, the C-terminal region, enriched in acidic residues and 
prolines.  
 
Despite the correlation with PD, the functions of AS are not completely 
understood. AS is highly expressed in the central nervous system and represent 
the 0.5–1% of total cytosolic proteins of brain homogenates. AS is concentrated 
at the presynaptic terminal, pointing out a possible role in the regulation of the 
synaptic functions 39. In order to study in vivo the normal functions of AS, 
knockout mice have been produced. In these transgenic model animals, the lack 
of AS decreased the number of synaptic vesicle available and the expression of 
synapsis-associated proteins at the presynaptic level. Although AS is not 
fundamental for synaptic formation and cell survival, a role of AS in the 
regulation of the vesicles release at the presynaptic membrane, in the neuronal 
plasticity 40–42 and in neurotransmission 40,43–46 was speculated. Some evidences 
confirm these hypothesis. It was observed indeed in yeast that one third of the 
genes involved in the toxic accumulation of AS are involved in lipid 
metabolism and vesicle trafficking. In Drosophila melanogaster as well, 
expression of genes involved in lipid transport are associated with that of AS 47. 
Moreover, in vitro experiments suggest a possible interaction of AS with 
phospholipase D2 and its inhibition 48,49.  Phospholipase D2 is a membrane-
bound enzyme, involved in the lipid-mediated cascades and vesicle trafficking. 
AS knockout mice have a decrease in the lipid uptake with a decrease in the 
assimilation of fatty acid inside the brain, suggesting that AS has a role in lipid 
metabolism 50,51. This is evident also at mitochondrial level, with the disruption 
of the mitochondrial membrane. Since AS does not bind the mitochondrial 
membrane, a role in lipid uptake and trafficking was speculated as well.  
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Finally, AS could be involved in the regulation of the concentration of DA at 
presynaptic level, acting on the anabolic pathway of the synthesis of DA or on 
the transporters of DA modulating the permeability of the plasma membrane to 
the molecule 52–54. It is also interesting to highlight a role of AS in the 
regulation of the transporters of serotonine and norepinephrine, suggesting a 
key role of AS in the homeostasis of these neurotransmitters and its presumable 
involvement in many brain functions 55 (Fig.1.7). 
 
 
 
Figure 1.7. AS is highly enriched in presynaptic terminals. A fraction of AS is associated 
with synaptic membranes, the other is cytosolic. When bound to phospholipid membranes, AS 
changes its secondary structure to α-helix. An important neuronal function of AS might be to 
regulate the formation of synaptic vesicles from early endosomes through interactions with 
phospholipase D2 (PLD2). Mutations in AS might result in a reduced number of vesicles being 
available for dopamine storage, leading to an accumulation of dopamine in the cytoplasm and 
increased levels of oxidative stress and cytotoxic dopamine by-product. From Lotharius at al, 
2002 56. 
 
1.3.1 AS interaction with membranes 
 
It is reported in literature that AS binds lipid membranes. In vitro studies, 
describe the binding of AS to synthetic lipid vesicles composed by mixtures of 
phospholipids such as phosphatidylserine (PS), phosphatidylglycerol (PG) and 
phosphatidyc acid (PA), or neutral phospholipids like phosphatidylcholine (PC) 
and phosphatilylethanolamine (PE) 57–59. In order to understand the 
   
18 
 
conformation of the protein upon binding, a series of studies was performed. 
Early studies using optical spectroscopies such as circular dichroism (CD) 
demonstrated an high transition to α-helical structure of AS bound to vesicles of 
different type 57,58. NMR measurements performed on membrane-mimetic 
sodium dodecyl sulfate (SDS) micelles suggested that the first 100 residues of 
AS are directly involved in the interaction and form two curved antiparallel 
helices with a linker represented by residues 38 to 44, maintaining the C-
terminal tail unfolded 60–62 (Fig.1.8). In this structure, lysine side chains of the 
repeated region point sideward from the helices which allow favourable 
interactions with the acidic sulfate groups on the SDS micelle.  
 
 
Figure 1.8.  Frontal and side view of micelle-bound AS. The membrane binding domain (gray), 
non-amyloid β component region, and acidic region are colored in gray, light blue, and red, 
respectively. Lysine residues found within the amphipathic repeats are shown. From PDB ID: 
1XQ8. 
 
 
According to the structure determined, it was suggested a partial insertion of the 
NAC region into the membrane 63,64 but no transmembrane arrangement was 
found 65–67. The AS binding to lipid membrane was supposed to occur into three 
main steps: first, electrostatic interaction between the amphipathic helices and 
the membrane interface occurs; second, a local rearrangement takes place and 
hydrophobic side chain insert partially into the membrane; finally, the protein 
folds into α-helices 68–70. 
In vitro, a series of factors influence the binding of AS to lipid membrane. First, 
it was observed a direct correlation with chemical properties of lipids. The first 
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study appeared in 1998 when it was suggested a preferential binding to anionic 
lipid (such as phosphatidylserine (PS), or phosphatidylinositol (PI)) probably 
due to electrostatic interactions with the lysine residues of the N-terminal 71 
(Fig.1.9).  
 
 
 
Figure 1.9. Model of AS vesicle bounded. (A) and (B) are representations of the interaction of 
AS with a curved lipid surface. (C) A more detailed image of the protein–lipid interaction. The 
N terminus of the α-helix is in the foreground. Lysine residues 58 and 60 are shown in space- 
filling format. (D) Cartoon representations of the structures of AS on micelles and SUVs. The 
small and highly curved micelles cannot accommodate the extended helical structure present on 
the membrane. (E) The repeat region residues are plotted onto a helical wheel in which 11 aa 
make up three turns. Lipid-exposed sites (red) fall onto one side, while solvent- exposed sites 
(green) lie on the opposite side. Adapted from Jao et al, 2008 67 
 
For this reason, the interaction is also strongly dependent on the ionic strength 
of the solution, with a decrease of α-helix as the concentration of salt in solution  
increases, although the binding is not completely absent even at higher 
concentration (>500 mM). Thus, although electrostatic forces play a key role in 
the binding process, they are not the only forces affecting the binding 71. 
Furthermore, the use of lipids with small head group facilitate AS binding, 
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probably because of the presence of more space for AS insertion. The chemical 
characteristics of the lipid chain can also influence AS binding. In particular, 
AS seems to prefer the binding of polyunsaturated lipids because they are 
responsible of a less packing of lipids leaving more defects available for AS 
insertion 72,73. 
Moreover, the curvature of the lipid membrane seems to be crucial in AS-
membrane interaction. Experiments of incubation of same amounts of AS in 
presence of lipid vesicles composed by PC/PA of different size, suggest higher 
affinity for small unilamellar vesicles (around 25 nm diameter) rather than to 
large unilamellar vesicles (around 125 nm diameter), indicating the higher 
membrane curvature as  a factor favouring the binding 57. Subsequent 
fluorescence correlation spectroscopy, site-specific fluorescence, isothermal 
titration calorimetry and gel-filtration studies confirmed the dependence of AS 
binding on vesicle size and therefore on membrane curvature 74–77, although the 
protein binds anionic large unilamellar vesicles 78,79 and even planar supported 
bilayers 80. The preferential binding of AS to vesicles with higher curvature 
could be due to the presence of a major number of packing defects in the 
membrane which facilitate the protein insertion 81,82. For this reason, 
complementary measurements with surface techniques on planar supported 
lipid bilayer could elucidate the role of AS-lipid membrane interaction 
removing the contribution of membrane curvature. 
Finally, AS interaction/colocalization with gangliosides (GMs) was described 
using CD spectroscopy and molecular simulations 83,84. GMs are 
glycosphingolipids composed of a ceramide backbone and one or more sugars 
as the headgroup and are supposed to bind AS through the formation of 
hydrogen bonds between sugar alcohols and AS side chains 84.  
AS-lipid interaction was widely studied in vitro but few is known about the 
interaction in living cells. GM1 ganglioside, together with cholesterol, is 
proposed to enrich lipid rafts, liquid ordered domains of the cell membrane 
involved in many cellular processes. In HeLa cells, it was observed the co-
localization of AS with GM1 and the specific association with lipid rafts was 
speculated 83. The same study was performed on the detergent resistant fraction 
extracted from HeLa cells membrane and supposed to be the raft domain of the 
cell, demonstrating AS association. The situation is anyway controversial and 
the AS binding to lipid rafts is still under debate. A confocal laser scanning 
microscopy study seems to highlight for example the preferential binding of AS 
to the liquid disordered phase of giant unilamellar vesicles (GUVs) instead to 
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lipid rafts. It is therefore still obscure whether AS prefer liquid ordered 
environment of lipid rafts or if the binding is mediated by its components (e.g. 
GM1 or GPI-anchored proteins). 
The cellular dysfunctions caused by the interaction of amyloid proteins with the 
cell membrane are usually due to a membrane destabilization upon binding. In 
particular, AS binding can cause the permeabilization of anionic membrane, 
alteration of the calcium flux, dispersion of intra-vesicular dopamine and 
depolarization of mitochondrial membrane 85, all phenomena potentially 
involved in PD. Moreover, atomic force microscopy studies and vesicle dye 
leakage assays reports on the capability of AS oligomers and fibrils of 
enhancing membrane permeability 86. In presence of anionic lipids and lipid 
disordered domains, the ability of AS of disrupting the bilayer is affected 87,88, 
although the specific mechanism of this disruption is still unclear. Other works 
suggest that AS can also transform membrane surface topology. In particular, 
AS binding to SUVs can induce the formation of tubular structure, 
multilamellar vesicles, and can increase the membrane curvature 89–91. These 
results highlight some points still unclear. Here, the necessity to validate these 
hypothesis with complementary techniques able to elucidate the effects of AS 
binding on membranes, the structural rearrangement in different conditions, the 
role of the lipid charge and lipid phase, fundamental for the comprehension of 
AS functions and its correlation with PD progress.  
 
1.3.2 The aggregation process  
 
The ability of AS to aggregate and form fibrils is abundantly described in 
literature but many aspects are still unknown. It seems clear that AS 
accumulation in form of aggregates and fibrils inside dopaminergic neurons is 
one of the early stages of the PD pathogenesis that lead to AS accumulation in 
Lewy bodies, but is still unclear how the formation of these aggregates triggers 
the cell death. AS forms indeed amyloid fibrils in vitro, similar to those 
observed in Lewy bodies in a concentration-dependent manner 92,93.  
It is important to underline that aggregates resulting from the AS self-
association in vitro are not actually always the same but it is possible to observe 
different types, depending on the experimental conditions. In particular, it is 
possible to create fibrils, oligomers and insoluble amorphous aggregates 
following three different pathways (Fig. 1.10). 
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Figure 1.10. The scheme summarize the possible pathways in AS aggregation. The natively 
unfolded AS monomer (Nu) forms a partially folded intermediate highly prone to the 
aggregation. Depending on the conditions, it can form soluble oligomers, insoluble amorphous 
aggregates, or insoluble fibrils. Adapted from Fink, 2006 94. 
  
The abnormal aggregation and accumulation of AS starts from a partially 
folded intermediate 95 that exposes contiguous hydrophobic residues able to 
enhance hydrophobic interactions between the molecules involved in the 
aggregation. The probability of the interaction between two of these species, 
even if it is low, can manifest after the formation of hydrogen bonds. The dimer 
can interact with other proteins starting the growth of soluble oligomers. Early 
formed metastable protofibrils typically comprise around 10 to 50 monomers, 
and appear as spherical in shape. These spheres may anneal to form chain-like 
protofibrils, which can further form annular pore-like species or proceed to 
amyloid fibrils 96,97. 
All the amyloid fibrils have in common a β-sheet structure in which beta 
strands are perpendicular to the main axis of the fibril 98 (Fig. 1.11). This means 
that the protein has to rearrange its secondary structure in order to allow the 
conformational changes required to obtain this structure.  
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Figure 1.11. Schematic representation of an amyloid fibril. Beta-sheets cross 
perpendicularly to the main axis of the fiber. 
 
It was demonstrated that oligomers are the most toxic species 99,100 and affect 
the cell viability. It is possible moreover to observe the formation of annular 
intermediates 101 able to disrupts membranes 86. 
For this reason, the comprehension of the conversion rate from the monomer to 
oligomers and, from here to fibrils, could be a crucial step in the understanding 
of PD evolution and will increase our knowledge of the process at the basis of 
this phenomenon.  
When AS is incubated at pH 7.4 at 37 °C, it starts to aggregate exponentially, 
with a kinetic typical of a nucleated polymerization (Fig. 1.12, blue line) where 
transient soluble oligomers are observed in the lag phase 96,99,102. These 
oligomers were studied with many different biophysical techniques in order to 
understand their role in fibrillogenesis. Using Dynamic Light Scattering (DLS), 
rapid formation of these oligomers was observed soon after AS incubation (Fig. 
1.12, red line). Their concentration grow up to 15-20% at the end of lag period, 
and rapidly decrease as soon as fibril grow increase (Fig. 1.12). Similar results 
were obtained by FTIR and FRET measurements 102. 
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Figure 1.12. Formation of oligomers during the AS aggregation measured by Dynamic 
Light Scattering. The red line represent the formation of transient oligomers measured as 
scattering intensity increase whereas the rate of formation of fibrils, monitored by thioflavin T 
fluorescence, is shown in blue. Adapted from Fink, 2006 94. 
 
Small angle X-ray Scattering (SAXS) measurements on AS solution soon after 
the incubation displayed the presence of the monomer only, while oligomers 
were found after 2 hours. These species are not stable in time, dissociate very 
rapidly and they are difficult to detect by other techniques such as size 
exclusion chromatography (SEC) high-performance liquid chromatography 
(HPLC). Atomic force microscopy (AFM) imaging displayed two populations 
of oligomers, one in the early lag phase having height of 2-3 nm, the other in 
the late one, having height of 5-7 nm, size more similar to mature fibrils. The 
decrease of these oligomers with the same rate of fibril growth suggest that 
fibrils probably could be formed by oligomers association, rather than by 
binding of monomeric species to the growing end of fibrils. 
It was reported that, as expected, an increase in the concentration of AS in 
solution, increasing the intermediate concentration, enhances the rate of 
fibrillation 103. Moreover, the presence of ions (anions and cations) in solution 
is critical in the aggregation process because can influence the formation of the 
folded intermediate and accelerate the fibrillation 104.  
The partially folded intermediate is stabilized by many factors such as an 
increase in temperature 105, low pH 105, metal ions 103,106 and organic solvents 
104. 
In particular, it was indeed observed in literature that solvents are able to 
influence the secondary structure of AS suggesting that the stability of the 
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protein is highly complex. In particular, Munishkina et al. 104 studied the effect 
of simple and fluorinate alcohols on AS secondary structure:  
 
 hexafluoroisopropanol (HFIP) starts an alpha-helix transition at 2.5% 
v/v which is complete at 30% HFIP in water;  
 ethanol (EtOH) is able to induce β-sheet conformation with the  
complete transition at 60% v/v;  
 methanol (MeOH) is able to induce β-sheet conformation with the  
complete transition at 40% v/v; 
 trifluoroethanol (TFE) is able to induce a more complex transition 
pathway, depending on the concentration. AS assume β-sheet 
conformation at 16% v/v TFE while it evolves to α-helix at 40% TFE. 
These forms are initially monomeric but start to aggregate over the time.  
 
Incubation of AS at 37 °C in presence of alcohols starts an aggregation process 
dependent on the solvent concentration. At low concentration, the fibrillation 
enhances probably because of the stabilization of the partially folded 
intermediate, previously described as the key form in the aggregation process. 
Increasing the concentration (e.g. >40% EtOH or MeOH), AS starts to self-
associate forming β-enriched oligomers that do not fibrillate, suggesting that 
oligomers formed in these conditions are quite stable. The incubation in these 
stabilizing conditions for several days gave indeed amorphous aggregates as the 
major component, even if some short fibrils were observed. 
AS aggregation could be inhibited in some other cases. It was observed in fact 
that nitration of tyrosine residues led to the formation of stable oligomers that 
occurs in vivo through the oxidation of tyrosine residues. In vivo, this nitration 
occur through the interaction with oxidative products of NO, which could lead 
to additional oxidative products of AS such as di tyrosine 107.  Since 
dopaminergic neurons are the most sensitive in PD, and dopamine shows high 
propensity to the oxidation, this suggested that, oxidized products of DA, 
stabilizing oligomeric forms of AS in vitro, could be involved in PD. 
 
1.3.3 AS-DA interaction 
 
The preferential vulnerability of dopaminergic neurons in PD is still unclear but 
it has been hypothesized a role for DA in the biology of AS 108. In particular, 
DA, forming AS-DA adducts, stabilizes the oligomeric, presumably toxic, 
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protofibrillar form of the protein and inhibits the formation of AS fibrils in vitro 
109 (Fig. 1.13).  
 
 
 
Figure 1.13. AS aggregation pathway. AS amyloid fibrils formation occurs through the 
formation of AS small oligomers that elongate in fibrils (route 1) as shown by electron 
microscope micrograph (scale bar 200 nm). DA disaggregates these unsoluble fibrils into 
soluble oligomers (route 2). AS monomer, in presence of DA produce off-pathway 
intermediates (route 3a) inhibiting the conversion into amyloid (route 3b). From Leong et al, 
2009 110. 
 
 
The hypothesis that protofibrils are actually the pathogenic species and that 
fibrils might represent a protective cellular response is consistent with 
pathological studies that suggest the neuroprotective role of Lewy bodies 111,112. 
For this reason, DA binding, stabilizing AS protofibrils, could promote PD 
pathogenesis 92. Another important function of the DA-modified AS, recently 
demonstrated, is to block chaperon mediated autophagy 113 but it is still unclear 
the ensemble of function and effects in living cells. 
The binding of DA to AS is suspected to be involved in PD pathology, as 
dopaminergic neurons are the most affected. Among the possible culprits, from 
oxidative stress to AS fibrillation, the interaction of DA to AS, whether in its 
native or oxidized forms, has in fact been reported as possible pathogenic 
events in the cascade leading to AS oligomerization and fibrillation.   
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In order to understand the nature of the AS -DA interactions, in vitro studies 
were performed. Truncations in the C-terminal of the proteins demonstrated a 
key role of the residues 125-129 (YEMPS) in the formation of the AS -DA 
adduct 114. Recently, theoretical modelling suggest a role of the long-range 
interactions with residues in the NAC region in the stabilization of the ligand 
115,116. Covalent 114,115,117,118 and/or non covalent 109,119,120 crosslinking of DA to 
AS has been reported.  
The morphology of dopamine-induces oligomers was studied with a range of 
biophysical techniques indicating a variety of different shapes and sizes 
109,121,122, without providing information about the binding affinity of DA to AS, 
important for the comprehension of the mechanism at the basis of this 
interaction. 
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2. Proteins at solid interface 
 
The immobilization of proteins on solid supports was introduced for analytical 
research some decades ago 123 and has found applications ranging from 
fundamental studies to biosensors. Although the study of biorecognition 
phenomena in solution is in fact often the easiest choice, this is not always the 
best one, especially in the case of IDPs, highly prone to the aggregation and 
difficult to handle with the classical in-bulk techniques. While the study of 
binding parameters in solution benefits of the isotropic distribution of the 
ligand, it is difficult to discriminate between bound and unbound molecules and 
therefore to quantify the portion of the bounded ones. For this reason, a careful 
labelling of the molecules, together with a sensitive way to discriminate 
between bound and free molecules is required, for the accurate monitoring of 
the reaction kinetics.  
The immobilization of the receptor on a solid support can overcome these 
problems allowing for the easy spatial separation of the bound from the 
unbound molecules. The main advantage of surface immobilization, compared 
to solution, is the possibility to tune the parameters of the immobilization 
process, and to control the localization and the stability of the molecules. As a 
drawback, the presence of a surface close to the protein could alter its function 
both because of unfavourable orientations with respect to the analyte in solution 
and because of electrostatic interactions.  
Among the analytical techniques for biorecognition studies on solid surfaces, 
surface plasmon resonance (SPR) is one of the most used. It measures the 
variation of the angle of minimum reflection of polarized light through the 
interaction with a functionalized metal. Such minimum (resonance angle) is due 
to the interaction of light with activated surface plasmons, and is proportional to 
the mass on the sensor surface. Monitoring the position of the resonance angle 
versus time during a bioaffinity reaction, allows getting information on the 
binding parameters, in real-time. Although this technique is label-free, many 
examples for heterogeneity of surface binding sites caused by immobilization 
have been reported 124–126.  
Another well-known example of solid-phase assay is the Enzyme-Linked 
ImmunoSorbent Assay (ELISA). This test is usually performed in a sandwich 
configuration: protein binder molecule, generally antibodies, are immobilized 
on a surface. The bound protein are detected through a secondo, enzyme-linked 
antibody. After the addition of the enzyme’s substrate, a reaction gives 
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colorimetric signal used to quantify the analyte. The first biomolecular layer is 
usually immobilized either via physisorption or grafted on the surface through a 
grafted site which is often randomly picked along the sequence and could even 
be buried in the middle of the protein. Clearly, a better control of surface 
heterogeneity is of critical importance for the development of biosensors and 
the characterization of macromolecular interactions.  
In this context, we propose here to carefully control the density and orientation 
of protein layers on gold surfaces for optimal biorecognition, by using 
nanografting, an innovative lithographic technique based on atomic force 
microscopy (AFM). A self-assembled, nano-sized monolayer of protein in 
controlled orientation is promoted by the tip of the AFM, and is embedded 
inside a bio-fouling carpet of self-assembled organic molecules. This allows at 
the same time for the miniaturization of the assay, making in principle possible 
to conduct the analysis in small sample volumes. Controlling the availability of 
active sites to the molecules in solution increases the sensitivity of the assay, 
particularly crucial when dealing with small volumes and a reduced number of 
analyte in solution. In our layout, AFM nanografting is used to localize the 
binder molecules. Sensitive AFM topography read-out is then used to measure 
the characteristics of the binding monolayer, and the successive binding of 
analytes.  
 
 
2.1 Atomic force microscopy 
 
The Atomic force microscope (AFM) is a surface imaging technique. It was 
developed in 1986 by Gerd Binning, Calvin F. Quate and Christopher Herber as 
“a combination of the scanning tunnelling microscope and the stylus 
profilometer” 127.  
It is considered part of the Scanning Probe Microscopy (SPM) family, a class of 
instruments that investigate the properties of a sample at or near the surface. 
They can be classified according the nature of the interactions measured 
between a probe and a sample (electrical, like STM, mechanical, such as AFM, 
optical, or a combination of these, like SNOM, Scanning Near-field Optical 
Microscopy). 
The AFM operates measuring the interaction between a sharp tip and a surface, 
using a flexible cantilever with a tip on the free end.  The tip typically is 
fabricated of silicon–oxide and has a radius of curvature of 10 nm for standard 
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probes (Fig. 2.1a). Smaller radii of curvature allows reaching higher resolution 
(Fig. 2.1b). For this aim, carbon nanotubes (CNT) terminated tips have been 
recognized among alternative choice for AFM probe due to the small diameter 
(<10 nm), robust mechanical properties and chemical inertness (Fig. 2.1c).  
 
 
Figure 2.1. SEM images of AFM tips. a) Example of one standard AFM probe. b) High 
resolution AFM tip. c) CNT-terminated AFM probe. 
 
The soft microsized cantilever has a spring constant that may vary according to 
the sample and the application (from few tens of pN/nm to few tens of nN/nm), 
that is function of the elastic constant of the material and cantilever dimension. 
The force of the interaction is not measured directly, but calculated measuring 
the deflection of the cantilever by a laser beam focused on the top of the free 
end of the cantilever and reflected on a four-elements position-sensitive 
photodiode (Fig. 2.2).  
Knowing the stiffness of the cantilever, in first approximation, the Hooke’s law 
gives the linearly relationship between the force required to deflect the 
cantilever and its deformation: 
F= -kz 
Where F is the force, k is the stiffness of the cantilever, and z is the distance the 
lever is bent. 
A piezoelectric actuator moves accurately the AFM probe and the sample in the 
X-Y plane in a raster manner. The number of lines scanned in a surface unit 
contributes to the resolution of the image. A Z-actuator, composed by 
piezoelectric material as well, controls the vertical movement of the tip. 
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Figure 2.2. Schematic representation of an Atomic force Microscope. A laser beam is 
focused on top of the free end of a cantilever and reflected on a four elements detector, sensitive 
to the laser shifts during the raster-like scanning of the sample.  
 
The AFM can work into two main mode: a static mode (contact mode), in 
which the probe is maintained in constant contact with the sample, and a 
dynamic mode (non-contact and intermittent mode) with an oscillating probe.  
 
2.1.1 Static mode: Contact mode (CM) 
 
The contact mode AFM is usually considered a static operation mode and, as 
the name suggests, the tip is in constant contact with the surface of the sample. 
Repulsive forces dominate the interaction between the probe and the sample. In 
ideal conditions, when the tip starts approaching the surface, long-range Van 
der Waals interaction predominates; when the tip is near (some Angstroms) to 
the surface, short-range repulsive forces dominate. From the measure of the 
cantilever deflection, it is possible to calculate the force of the interaction 
between the probe and the surface, qualitatively described by the Lennard-Jones 
potential curve (Fig. 2.3).  
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Figure 2.3. AFM force-distance curve. From this curve, it is possible to understand the role of 
the different interactions depending on the distance between the tip and the sample. The tip, 
approaching to the surface, starts to feel attractive long range forces (non-contact AFM region) 
until tip and surface electron orbitals are so close to start exerting repulsive forces (contact 
mode AFM region). Between these two regimes lies the intermittent-contact (or tapping mode) 
region. 
 
During the scanning, the deflection signal gives the vertical deflection of the 
cantilever; the error signal is the difference between the deflection signal and 
the AFM feedback system’s setpoint value, and it is the input to the feedback. 
The output of the feedback guides the z-actuator, which moves the sample or 
the probe in the z-direction in order to maintain the interaction with the surface 
constant. In this way, it is possible to reconstruct the topographic profile of the 
sample (Fig. 2.4).  
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Figure 2.4. Schematic diagram Atomic Force Microscopy feedback system. Adapted from 
“The AFM Almanac”, Agilent Technology. 
 
CM-AFM gives the possibility to have a high lateral resolution, which in some 
conditions, depending on the characteristics of the tip and the sample damage, 
reaches the atomic resolution of the sample. One of the main advantages of the 
AFM is the possibility to perform measurement on conductive and non-
conductive samples both in air and in liquid environment, particularly relevant 
in the case of study of biological samples, like DNA molecules, living cells or 
nanopatterned biomolecules. In this case, the set point is usually maintained 
below 100 pN in order to preserve the integrity of the sample 128. 
 
2.1.2 Dynamic mode: Non-Contact and Tapping mode 
 
In dynamic mode, the AFM cantilever is driven to oscillate near its resonance 
frequency. The amplitude of this oscillation is used as feedback parameter for 
the imaging of the sample. Martin et al 129 proposed for the first time in 1987 
the use of the atomic force microscope in oscillating mode with a small 
vibration amplitude (below 1 nm), to connect the variation of this oscillation 
with changes in the derivative of the force along the normal to the surface. 
Later, Zhong et al. 130 proposed to increase the amplitude of the oscillation (up 
to 100 nm) in order to avoid the trapping of the tip by surface forces (in air) and 
the method was named tapping mode.  
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In Non Contact-AFM (NC-AFM) the tip is positioned at a certain constant 
distance from the surface (within few of nanometers) where attractive forces 
(electrostatic, magnetic, attractive van der Waals forces) predominate. Once the 
tip approaches the surface, it starts to feel it. Variations in the resonance 
frequency, the amplitude and the phase of the oscillation are linked to the 
characteristics of the surface and to the tip-sample interactions. All these 
parameters are monitored in order to reconstruct the topography of the sample. 
  
In the case of Intermittent Contact Mode (or Tapping Mode), the amplitude 
of the oscillation, influenced by long-range forces, controls the feedback system 
and the error signal (difference between the setpoint and the amplitude) is the 
input for the feedback system. The output, as in CM-AFM, controls the z-
actuator and the tip movement. Moreover, during the scanning it is possible to 
record the variation in the phase of the oscillation. This signal is particularly 
useful in the case of a heterogeneous material because gives information about 
the chemical properties of the sample. Since the tip touch intermittently the 
surface, the damage of the sample is significantly reduced.  Despite the 
difficulties of operating in tapping mode in liquid environment due to the 
significant dumping of oscillation frequencies by the viscosity of the aqueous 
medium, it is widely applied in biological field for the study of living cells, 
lipid membranes, DNA molecules and amyloid fibrils 131,132 
 
2.1.2.1 Force-modulation microscopy (FMM) 
 
The force modulation microscopy is an AFM mode in which the sample is 
scanned in contact mode, maintaining a constant cantilever deflection. In 
addition, a periodic vertical oscillation is applied either to the tip or to the 
sample with a frequency typically on the order of hundreds of kHz. The tip 
motion is converted in an electric signal composed by two components: a DC 
voltage signal that represents the tip deflection during the contact imaging, used 
by the feedback system to maintain a constant force and generate the 
topographic image of the sample; an AC signal obtained from the tip response 
due to the oscillation. In particular, harder is the surface larger is the deflection 
of the cantilever and the amplitude response whereas softer is the surface 
smaller is amplitude response, due to the partial absorption of the oscillation. 
From a practical point of view, the amplitude value (pA) is proportional to the 
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substrate stiffness. FMM-AFM can, consequently, reconstruct a 2D image 
where colour contrast is representative of surface stiffness distribution: brighter 
colours means higher stiffness and vice versa. The amplitude of the AC signal 
(called ‘FMM Amplitude’) is sensitive to the elastic properties of the sample 
surface. Depending on the elastic properties of the sample, it is possible to 
record an FMM image that could be used as a map of the sample stiffness 
(Fig.2.5). 
 
 
Figure 2.5. FMM AFM-mode. During the scanning the AFM tip is in constant contact with the 
sample while the tip (or the sample) oscillate. The sample surface is periodically pushed by the 
tip, and the change in cantilever oscillation amplitude can be related to elasticity of the sample 
surface. 
 
Knowing the scanner vertical displacement (Dz), the probe tip vertical 
displacement (D) and the cantilever force constant (Kc), it is possible to 
determine the local elasticity of the sample (Ks): 
Ks= Kc (Dz/D-1) 
Moreover, knowing the local elasticity of the sample it is possible to calculate 
the Young’s modulus of the sample using for example the Hertzian model of 
the elasticity or comparing calibrating samples with known values. Force 
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modulation measurements are widely used in polymers, semiconductors, 
biological samples, especially for the study of composite materials. 
 
2.2 AFM nanolithography: nanografting 
 
The spontaneous self-assembly of thiols on a gold surface is well understood. 
Self-assembled monolayers (SAMs) are ordered, compact molecular structures 
driven by forces that span over different scale lengths: usually chemical 
interactions between molecular end-groups and the surface, and long-range 
dispersion forces (e.g. van der Waals forces) between the molecular tails. 
Alkanethiol SAMs on metals, and particularly on Au, are widely used in many 
different fields because of the easy preparation (Fig. 2.6), the stability and the 
strength of the S-Au bond. 
 
 
 
Figure 2.6. SAM preparation procedure. The substrate is immersed into a solution containing 
the molecules of interest having at one end a specific group capable to react with the surface of 
the substrate forming a bond. Finally, a packed ordered layer of molecules is spontaneously 
assembled. 
 
The quality of the SAM could be affected by a series of factors that introduce 
defects in the organization of the layer. For example, crystallinity, roughness, 
cleanliness of the gold substrate, the temperature at which the sample is 
prepared, the immersion time, the concentration of molecules in solution are 
some of many parameters that affects the homogeneity of the SAM. SAMs 
prepared from solution are therefore far to be perfect. Still, they work as good 
passivation layers.  
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SPM and diffraction studies demonstrated that unconstrained self-assembly of 
alkanethiols on gold is composed of two main steps. In the first step, the 
process implies an initial physisorption, in which thiolated molecules adsorb on 
the surface through van der Walls interactions. This phase could also be 
described as a gas-like, highly disordered system, and is followed by the 
chemisorption of flat-lying molecules on Au through the S-heads (a process that 
takes seconds). This ordered phase is called lying-down phase or stripe phase, 
with the chain parallel on the surface. In this phase, alkanethiol molecules bind 
to the Au substrate through the S head by losing the mercaptan H atom, turning 
in alkanethiolates. Ordered flat-lying surface structures, known as striped 
phases are then formed. The increase in the surface coverage results in the 
nucleation of ordered domains (a process that can take some minutes or even 
hours depending of the molecules’ concentration) of standing-up molecules that 
finally cover the entire gold surface. In this phase, called also standing-up 
phase, the molecules start up to stand with their longitudinal axis tilted of 30° 
with respect to the surface normal, forming a compact layer as the result of 
lateral van der Waals interactions between the chains 133. In a normal SAM, 
grown at room temperature, the molecules follows the Langmuir (or modified 
Langmuir) absorption kinetics, with two time-scale characteristic of the two 
ordered phases, laying-down and standing-up (Fig. 2.7b). 
 
Nanografting is a lithographic AFM mediated technique, developed by Liu et al 
in 1997 134. It requires as a starting step a SAM covered surface: it promotes the 
local exchange between molecules of the SAM and other thiolated molecules 
present in solution, forming confined nanostructures of one kind of molecules 
embedded in a SAM carpet of other molecules. The methodology is very 
simple: a self-assembled monolayer (SAM) of alkanethiols, typically oligo 
ethylene glicole terminated, is grown on an ultra-flat gold surface (template 
stripped gold, TSG) and is used as reference carpet for topographic 
measurement of the surface. The main property of this SAM is to be 
biorepellent, to prevent the aspecific adsorption of molecules on the surface 135. 
For this reason, it does not change during the experiment (as can be verified by 
AFM roughness measurements). The scan of the tip at high force (around 100 
nN) permits the local displacement of the reference molecules that are replaced 
by thiolated molecules of interest dissolved in the liquid medium. The thiols in 
solution in fact, being highly concentrated with respect to the thiols displaced, 
bind to the exposed gold surface. In this way, it is possible to immobilize the 
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molecules in a well-oriented manner with high control and precision. The 
imaging at low force (<100 pN) gives topographic height data of our nano-
confined self-assembled monolayer, from now on referred to as NAM, 
nanografted assembled monolayer  (Fig. 2.7 a).  
The spatial confinement of the free gold surface, inhibits the formation of lying-
down phases in NAMs, favouring directly the standing up configuration and, 
under identical reaction conditions, self-assembly occurs much faster in NAMs 
than in unconstrained SAM. It was demonstrated moreover that the order and 
the packing of the nanografted molecules is much higher than the 
spontaneously assembled layer, as can be seen in Fig. 2.7b 133. Moreover, under 
identical reaction conditions, self-assembly occurs much faster during 
nanografting than in unconstrained self-assembly (Fig. 2.7b). 
 
 
Figure 2.7. Nanografting vs unconstrained self-assembly. a) Nanografting procedure. The 
scanning of AFM tip at high force diplace the molecules of a reference SAM of thiols 
promoting the replacement with the thiolated molecules of interest dissolved in solution. b) 
topographic images of C18 nanografted (right square) and self-assembled on bare gold (left 
square).  Notably, self-assembly in spatially confined process like nanografting is much faster 
than the spontaneous unconstrained self-assembly. Adapted from Liu et al, 2008 133 
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The simplified adsorption kinetics in NAMs with respect to SAMs, implies a 
reduced amount of defects, which are in part connected to grain boundary 
formation in the laying-down to standing-up transition. In order to prove the 
increased order in a NAM compared to a SAM, the autografting approach was 
introduced. In this case, 1-octadecanethiol (C18) was nanografted inside a SAM 
of the same molecule. The CM-AFM topographic image of a 1-octadecanethiol 
(C18) patch enclosed into a C18 SAM was simultaneously acquired with 
friction image (Fig. 2.8). The tip is moved at fixed load and the cantilever 
torsion due to the tip/surface interaction is recorded (lateral force). The 
cantilever twisting is constant during scanning on a perfectly homogeneous 
surface, while it increases or decreases because of changes either in the gold 
surface morphology (boundary edges, surface steps or holes, but also gold 
surface roughness) or in the molecular film properties. In order to avoid the 
contribution of geometric characteristics of the sample, the net friction force 
image is obtained as the difference between the two lateral force signals 
(forward and backward trace). Friction signal is very sensitive to variation of 
the chemical properties of the sample that influences the proximity interactions 
with the tip, and give additional information for the sample characterization. 
 The topography of the patch is almost indistinguishable while, the friction 
image clearly displays the patch as a decreasing in contrast, suggesting that the 
tip moves more freely on the patched area. This experiment points out the better 
molecular packing and order of the molecules of a NAM respect to that of a 
SAM.  
 
Figure 2.8. (A) Topographic image of an autografted C18 patch enclosed into a C18 matrix 
SAM and (B) the simultaneously acquired friction image. It is almost impossible to detect the 
patch in topography but there is an evident contrast reduction in the friction image. Darker areas 
mean lower cantilever torsion, so lower tip/surface lateral interaction. From D. Scaini, PhD 
thesis 136. 
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Conductive tip AFM (CT-AFM) measurement were also performed in order to 
confirm these speculations. Current flow is indeed very sensitive to the 
molecular order giving the possibility to appreciate defects more than AFM 
friction analysis. Topographic and current images of a 1-decanethiol (C10) 
autografted were simultaneously acquired (Fig. 2.9). 
 
 
Figure 2.9. Topographic image of an autografted C10 patch enclosed into a C10 matrix SAM 
(A) and  the simultaneously acquired current image (B). As in the previous friction case it is 
almost impossible to detect the patch in topography but it is evident in the current image. 
Current was acquired at negative bias that means currents are negatives and flow entering the 
patch plane. Consequently, darker areas mean larger negative currents. Current profile of the 
evidenced white line in the current image (C). Increased current homogeneity of the patch is 
evident and, moreover, a drastic reduction in current spikes (dark spots) is evident in the 
nanopatch that looks more uniform. Gold grain boundaries induce large currents probably due 
to tip/gold surface short contacting. From D. Scaini, PhD thesis 136  
As observed in the previous experiment, also in this case the topography of the 
autografting is almost inappreciable, while it is possible to observe the grafted 
area in the current image. Analysing the current signal, it reveals the presence 
of current spikes at the edge of the patch and in the SAM area while no defects 
are present in the nanografted area. The main value of the current flow inside 
and outside the patch is the same but clearly more uniform in the NAM 
(unpublished data 136).  
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Another important advantage of the deposition of molecules through 
nanografting is the possibility to control the density of the molecules 
immobilized, tuning the fabrication parameters: the concentration of the 
molecules in solution, the force used during the displacement and the ratio 
between the scanned area and the total area of the confinement (S/A parameter) 
(Fig. 2.10). 
 
Figure 2.10. Surface density moculation via Nanografting. Molecules’ packing density tuned 
by changing the scan density ration, that is the ratio between the actual area scanned by the tip 
and the total area of confinement. A visual cartoon is depicted in the specific case of a 
tip/surface contact area diameter of 10 nm, image size of 160×160 nm2, and the number of line 
wrote by the tip on the fast scanning direction (pixels) are indicated in the three cases. 
 
2.3 Immobilization strategies 
Proteins can be immobilized on a gold surface by exploiting different chemical 
approach. In the following sections, some of them are described. 
2.3.1 Non-covalent adsorption 
This approach is widely used for the immobilization of proteins through non-
selective interactions between the protein and the surface. The immobilization 
is due to physicochemical interactions such as hydrophobic adsorption or 
electrostatic interactions on charged materials. These interactions could be 
sufficient for the stable immobilization of the molecules but the orientation and 
the distribution of the molecules is extremely uncontrolled.  
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2.3.2 Covalent binding of proteins 
 
2.3.2.1 Cysteine-tag 
 
A good strategy for the immobilization of protein on a gold surface is the 
addition of a di-cysteine tag in a specific position of the protein (usually on the 
C or N-terminal of the protein). In this way, using the gold-sulphur chemistry, it 
is possible to immobilize a protein in a well-oriented manner by specific 
covalent bond.  
The main disadvantage of this approach is that the folding of the protein could 
be affected because of the formation of disulphide bond between the cysteine of 
tag and the cysteines along the sequence. 
This strategy was successfully used for the direct immobilization, by 
nanografting, of the maltose binding protein (MBP) 137 and combinatorial 
protein S-284-C138 (Fig. 2.11). 
 
 
 
Figure 2.11. Cartoon depicting a direct nanografting of de novo polypeptides. From Hu et al, 
2005 138. 
 
2.3.2.2 Amine-coupling 
 
Amine-coupling represents another strategy to immobilize proteins trough a 
chemical reaction. In this case, a surface functionalized with carboxyl 
terminated molecules, and activated by 1,3-dicyclohehylcarbodiimide (DCC) 
and N-hydroxysuccinimide (NHS), is available to react with amine groups in 
lysine side chains of the protein (Fig. 2.12). The main advantage of this 
approach is the chance to immobilize protein in a stable manner without any 
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protein modification although this strategy does not usually provide any 
selective reactivity. 
 
Figure 2.12. Amine-coupling. Activated carboxylic groups react with amine groups of the 
polypeptide chain. Adapted from Cooper et al, 2002 139. 
 
2.3.3 Bioaffinity interactions 
 
2.3.3.1 Histidine-NTA 
 
The poly-histidine tag is the most common affinity tag genetically encoded, 
realized for the first time by Hochuli et al in 1988 140,141. This tag is usually 
composed by six histidines, which chelate metal ions such as Cu (II), Co (II), or 
Ni (II), although the latter is the most commonly used. A chelating moiety such 
as nitrilotriacetic acid (NTA), known for chelating Ni, is employed in order to 
produce a support presenting the metal ions. In this way, it is possible to 
immobilize the proteins through its histidine tag (Fig. 2.13). This method is 
widely used for the purification of recombinant proteins by immobilized metal 
affinity chromatography (IMAC) 141 and for this reason protein histidine-tagged 
modified are easily commercially available. This tag is usually located at one of 
the two termini of the protein, in order to maintain the capability of the binding 
to metal ions independent from the secondary structure of the protein. 
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Figure 2.13. NTA-Ni(II)-His-tag Immobilization Strategy. NTA-functionalized support 
coordinates a Ni (II), which trap proteins through interaction with their histidines.  
 
The main advantage of this technique is the possibility of the oriented 
immobilization of proteins on a surface. It was applied in microarray field and 
for nanofabricated SAMs as well 142–144. Moreover, it is interesting for the 
possibility to remove the protein and reuse the NTA-functionalized surface 
exploiting the imidazole affinity for NTA.  
 
2.3.3.2 DNA-Directed protein Immobilization (DDI) 
 
Proteins modified by the chemical addition of a short ssDNA strand can be 
immobilized via Watson-Crick base pairing onto ssDNA NAMs. In this way, 
ssDNA array can be easily transformed, with good efficiency, into a protein 
array (Fig. 2.14). The process is named DNA Directed Immobilization (DDI). 
The main advantage of the DDI strategy, is the possibility of multiplexing: 
different ssDNA sequences can be immobilized on the surface, and used to 
address different proteins conjugated with the respective complementary DNA 
tails. By nanografting, DDI immobilization of Streptavidin, Glucose oxidase 145 
and Gliar Fibrillary Acidic Protein (GFAP), a potential cancer biomarker for 
glioma, was performed successfully (see Appendix). 
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Figure 2.14 Schematic representation of DNA Directed Immobilization strategy. The 
hybridization of nanografted ssDNA with the complementary strand, conjugated with the 
protein of interest, lead to the conversion of DNA NAMs into a protein array.   
 
 
2.4 AFM nanografting: a potential tool for the study of IDPs 
 
Nanografting technique was successfully exploited for the immobilization of 
biomolecules and applied for different studies 146–148. Through the 
immobilization of proteins was possible to prove the stability and activity of 
nanografted molecules 149, naturally exploitable for biosensing studies 145. The 
technique was indeed successfully employed for the study of binding affinity 
parameters 137,150. For all these reason nanografting could be a solution for the 
study of IDPs, difficult to handle with other approaches. For example, the 
technique has been already exploited in our lab for the immobilization and 
study of the prion protein (PrP). The prion (PrPSc) is a conformationally altered 
isoform of the prion protein (PrP), a normal membrane-anchored protein.  
Great concern arises in the scientific community when the transmission via 
meet consumption was assessed through blood transfusion to a recipient patient 
was disclosed. Therefore, as current detection techniques are unable to detect 
PrPSc at the suspected infectious concentration in blood, the development of a 
technique able to detect the presence of the protein is required.  
Via precise interfacial nanostructure measurements, the characterization of 
antigen-antibody biorecognition phenomena was performed on the 
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nanostructured array with unprecedented control over PrP orientation (Fig. 
2.15).  
 
Figure 2.15. Cartoon of the oriented immobilization of recombinant mouse PrP 
(recMoPrP). After nanografting of NTA-EG3-C16-SH into a reference carpet of protein 
repellent EG3-C11-SH, histidine-tagged Fabs (CloneP, on the left, and D18, on the right) are 
immobilized. Afterward, the sample is incubated in a solution containing recMoPrP 300 nM. At 
each step of the assay, topographic measurements (CM-AFM profiles are reported here) are 
collected for each nanopatch. From Sanavio at al., 2010 151 
 
 
 
Figure 2.16. Dose-response curve. The blue curve report the differential height of recombinant 
mouse PrP after its addition on Clone P patches. The gray line reports the roughness variation 
of the same patches. In both cases the dissociation constant has been calculated (Kd= 2.9 nM 
and 1.5 nM respectively). From Sanavio at al., 2010 151 
   
47 
 
In this case, in fact PrP was immobilized in two different orientation, through 
the interaction with two distinct antibodies (Fab) immobilized on the surface 
through NTA-histidine chemistry. Therefore, the relative titration curves have 
been obtained 142 (Fig. 2.16). 
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3. Proteins at model membranes 
 
The cell membrane represents one of the most complex components of the cell. 
It separates the internal cell environment from the external one, contributing to 
maintain the cell homeostasis. Moreover, it selectively allows the transition of 
ions and organic molecules, it is responsible of signalling processes and is 
constituted essentially by lipids and proteins. Inside eukaryotic cell, lipid 
membranes surround also cellular organelles, as endoplasmic reticulum (ER), 
Golgi body, mitochondria. In spite of their different functions, all biological 
membranes have in common a lipid bilayer structure. When different lipids are 
present, there is the possibility they segregate forming domains called lipid 
rafts, recently suggested as involved in signal transduction, membrane 
trafficking pathways and neurotransmission 152. The proteins associated with 
the membrane are much less characterized than soluble ones, although they 
represent the 15-39% of the human proteins. Understanding functions and 
characteristics of proteins that bind lipid membranes could be fundamental to 
see through many cellular processes. Among them, there is AS, which 
characteristics and functions are still unclear in many aspects, as already 
described in the first chapter. The use of model membrane is widely used in 
literature in order to simplify a complex system and try to perform a 
fundamental study at the basis of these interactions. In the following section, 
informations about membrane composition, assembly and study are briefly 
described. 
 
 
3.1 Membrane composition and phase separation 
 
Essentially, three main classes of lipids compose living and artificial cell 
membranes: 
a) diacylglycerol-derived lipids,  
b) sphingosine-derived lipids 
c) sterol lipids (cholesterol). 
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Figure 3.1. Structure of membrane lipids: diacylgycolipids (a), sphingolipids (b), and sterol 
lipids (cholesterol, c). 
 
Diacylglycerol-derived lipids include phosphatidylcholines (PCs), 
phosphatidylethanolamines (PEs), diacylglycerols (DAGs) and glycolipids with 
a glycosidic bond between the carbohydrate and the head group.  
Sphingolipids are derived from the binding of a sphingosine base and an acyl 
chain through an amide bond. Sphingomielin (SM), having a phosphorylcholine 
head group, is one of the most represented sphyngolipids in brain (Fig.3.1). 
Respect to glycerolipids, they are characterized by much more higher melting 
temperature (Tm), which can be over 60 °C. 
Lipids spontaneously self-assemble forming a bilayer. This assembly is 
tremendously dependent on the temperature. Every lipid has indeed a Tm that 
varies with the length and degree of saturation of the acyl chains.  Below Tm, 
they can assembly into a solid (gel, solid ordered, So or Lβ) state in which the 
alkyl chains are well ordered in a crystalline hexagonal lattice and the alkyl 
chains are all in trans conformation; above Tm, the fluid (liquid-crystalline, 
liquid disordered, Ld or Lα) phase is observed, in which one or more double 
bond of the alkyl chain are in the gauche conformation 153,154. In general, lipids 
with unsaturated acyl chains increase their propensity to be in a Ld phase, the 
packing is low and the thickness of the bilayer decreases.  
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Cholesterol is the main constituent among sterol. The structure of cholesterol is 
very different from the other lipids. It is characterized by a highly condensed 
hydrophobic rigid area represented by a series of planar fused rings. The 3-
hydroxy moiety is the only hydrophilic part (Fig. 3.2a). After the insertion of 
cholesterol inside the lipid bilayer, the rigid body is located alongside the fatty-
acid tails of phospholipids and can help the order of these chains. 
  
 
Figure 3.2. a) The structure of cholesterol. It is composed by a rigid part of fused rings, a polar 
hydrophilic group and a hydrocarbon hydrophobic chain. b) Cholesterol, like other membrane 
lipids, has both hydrophilic and hydrophobic poles that determine its positioning within the 
lipid bilayer. When the hydroxyl group is next to the phospholipid ester carbonyl, the rigid body 
of cholesterol is situated alongside the fatty-acid tails of neighbouring phospholipids and can 
help to order these tails. From Maxfield et al, 2005 155. 
 
The interaction of cholesterol with other lipids is preferential for certain lipids. 
In particular, complexes with lipids such as SM through hydrogen bonds are 
observed 156. Moreover, cholesterol, inserted perpendicularly into the lipid 
bilayer (Fig. 3.2b), reduces the bilayer permeability, while the effect on lateral 
diffusion of proteins and lipids in the plane of the bilayer is minimal 155. 
Cholesterol, filling the interstitial spaces, increases the rigidity of the membrane 
and the packing of the acyl chains. This has an effect on the lipid phase. This 
particular lipid organization is called liquid ordered phase (Lo) in which the 
molecules are more tightly ordered and packed than in the Ld phase. In fig. is 
reported the phase diagram of DPPC in presence of cholesterol. At low 
cholesterol concentrations, Lo phase is in equilibrium with the Ld phase up to 
about 30 mol %, while at high concentrations (more than 30 mol %), Lo phase 
only is observed and DPPC thermal transition disappears 154.  
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Figure 3.3. Role of cholesterol a) schematic representation of the Ld So Lo phases. Cholesterol 
insertion (black oval) lead to a Lo phase. b) DPPC phase transition diagram. An increasing 
amount of cholesterol stabilizes the ld phase above the chain-melting temperature of DPPC. The 
phase transition disappears at levels above 30 mol% cholesterol, which leads to Lo phase only.  
Adapted from Binder et al, 2003 154 
 
This explains the high cholesterol content of biological membranes (around 35 
mol %) in which the phase transition diminishes. The Lo phase is associated to 
lipid rafts domains in the real cell membrane. 
In vivo, phospholipids, cholesterol and sphingolipids are between the main 
components of the most common membrane, although the precise composition 
depends on the cell type and the membrane localization. 
In particular, the  major component of synaptic vesicles membrane is 
phosphatidylcholine (PC, 40.9 mol%), then phosphatidylethanolamine (PE), 
sphingomyelin (SM), plasmenylethanolamine, phosphatidylserine (PS), and 
phosphatidylinositol (PI) (24.6, 12, 11.5, 7.3, and 3.7 mol% respectively). High 
level of cholesterol is present (38.5% of total lipid content) 157. 
Moreover, it is important to consider that the composition of lipid membranes is 
asymmetric. For example, the outer leaflet is rich in PC and SM, while it is 
possible to find negatively charged lipids as PA, PG and PS in the inner leaflet 
of the plasma membrane 158. 
 
 
3.1.1 Lipid rafts 
 
“Lipid rafts” 159 were discovered as the fraction of the natural cell membrane 
resistant to treatment with non-ionic detergent (Triton X-100 at 4 °C) 160. This 
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portion of the membrane is rich in sphingolipids and cholesterol, which interact 
through the formation of hydrogen bonds between the OH groups of cholesterol 
and NH group of sphingosine or through the interaction between cholesterol 
and sphingolipids with long alkyl chains. Moreover, lipid rafts are rich in lipid-
modified proteins containing saturated acyl chains such as GPI-anchored 
proteins or doubly acylated Src-type kinases and transmembrane proteins 161 
(Fig. 3.4). 
 
 
Figure 3.4. Schematic representation of lipid rafts in the cell membrane. Lipid rafts are 
rich in sphingolipids (brown head, blue tails) and cholesterol (in yellow). Moreover, 
glycolipids, GPI-anchored proteins and transmembrane proteins enrich these domains of the 
membrane. 
 
The distribution of lipid rafts on the cell membrane surface depends on the cell 
type. For example in vitro, lipids rafts accumulate in the apical plasma 
membrane in epithelial cells, while in the axonal region in neurons. Few rafts in 
basolateral and somato-dendritic membranes respectively are detected 159. Lipid 
raft are mostly abundant in the plasma membrane but they are observed in 
biosynthetic and endocytic pathways too. Few is known about lipid rafts, and 
the main reason is the difficulty to visualize them on cells because too small to 
be characterized by conventional light microscopy. In fibroblast, for examples, 
rafts assembly into 50 nm diameter domains 162. It is still unclear the 
mechanism of proteins insertion but up to 15 equal proteins were observed in 
the same raft 163, supporting the hypothesis of a certain specificity of the 
binding. 
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3.1.2 Lipid rafts and disease 
 
Recent experiments, focusing on the study of the cell membrane, have 
demonstrated an important role of lipid rafts in biological activities. In 
particular, proteins associated within those domains have been demonstrated to 
be fundamental in many cellular functions such as signal transduction, protein 
and lipid sorting, cell adhesion and motility. In particular, they are related to 
many neurodegenerative diseases 164. For example, a form of the prion protein 
(PrP), responsible of transmissible spongiform encelopathies (TSEs) have a GPI 
anchor and seems to localize inside rafts. The mechanism of the pathogenesis 
require the conversion of PrP into the pathogenic form PrPsc which seem to be 
inhibited by a decrease of cholesterol that lead to the detachment of the raft 
associated proteins 165. Alzheimer’s disease (AD) is characterized by the 
abnormal accumulation on Aβ (amyloid-β-peptide) produced by the precursor 
cleavage by β- and α-secretase, both localized on membrane rafts. A reduction 
of cholesterol decrease the formation of Aβ peptide 166. Parkinson’s disease is 
related to lipid rafts too. In particular, in the early stages of PD, the composition 
of lipid rafts in the frontal cortex of incidental PD (iPD) is altered and 
comparable to PD cases in advance stages. The concentration of long chain 
polyunsaturated fatty acids (LCPUFA), which plays a role in the stability of 
rafts, decreases dramatically, where SM, cholesterol and saturated fatty acids 
concentration increases in cortical lipid rafts. Lipid rafts becomes more ordered 
compared to the age matched control, leading to an indication of progressive 
neuronal dysfunction. Moreover, low concentration of LCPUFA facilitates the 
aggregation of AS in the early stages of the disease. For this reason, the study 
of lipid rafts could be fundamental for understanding the processes at the basis 
of pathogenic events 164. 
 
3.2 Artificial lipid bilayers 
 
Artificial lipid bilayers are widely used as model in membrane-protein binding 
studies in vitro. Lipid molecules, composed by hydrophilic head group and 
hydrophobic tails, spontaneously self-assembly in liquid environment, in order 
to hide their hydrophobic core. Depending on the molecular characteristics, 
lipids could form: 
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A. micelles, spherical structures composed by a single layer of lipid, in 
which lipid hydrophobic chains are toward the center and the 
hydrophilic head groups are toward the external aqueous solution; 
 
B. vesicles, spherical structures composed by two lipid layers in which 
lipid hydrophobic chains face the others, while hydrophilic head groups 
are exposed to the liquid internal and external environment; 
 
C. planar lipid bilayers. 
 
Lipid vesicles could be prepared as multilamellar (multiple layers) or as 
unilamellar (single lipid layer). Unilamellar vesicles are easy to prepare and to 
manipulate and are a good model for the study of biomembranes in vitro. They 
are classified according their dimensions as small (SUVs, 10–100 nm), large 
(LUVs, 100 nm) and giant unilamellar vesicles (GUVs, >1 μm) and are usually 
used as model system for small trafficking vesicles (SUVs) and cellular 
membranes (GUVs) (Fig. 3.5).   
 
 
  
 
Figure 3.5. Schematic representation of different model artificial lipid bilayer commonly used 
in biophysical research and their approximate size. Adapted from Pfefferkorn et al, 2012 167. 
 
Supported lipid bilayers are robust and stable and give the possibility to use 
common surface analytical techniques. In order to obtain a good lipid layer, 
with few or no defects, the solid support should be hydrophilic, flat and 
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perfectly clean. For these reasons, mica 168–170, silicon 171,172 and glass 173 are 
widely exploited. 
Planar supported lipid bilayer (SLB) can be prepared using different methods. 
The most used are briefly described: 
 
1. Langmuir-Blodgett (LB). The experimental apparatus consists in a 
Teflon bath with movable barriers. Lipids are deposited at air-water 
interface dissolved in solvents. The movement of the barriers is used in 
order to compress lipids and a pressure vs area isotherm could be 
recorded, giving information about the lipid packing (Fig. 3.6-3.7a).  
 
 
 
Figure 3.6. Theoretical pressure vs area isotherm obtained compressing an insoluble lipid 
monolayer at air-water interface. At low pressure, the area covered by lipid molecules is high 
because of the lack of layer organization (gas phase). Increasing the lateral pressure, the 
molecules start to standing up (liquid phase) until the formation of a uniform monolayer (solid 
phase). 
 
 
The lipid monolayer is then transferred on a solid support moved through 
the solution with constant lifting speed (Fig. 3.7b). At this point, it is 
possible to obtain a lipid bilayer transferring a second lipid layer (Fig. 
3.7c). 
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Figure 3.7. Schematic representation of Langmuir-Blodgett technique. An organic solution 
of lipids is deposited on a water bath. After solvent evaporation and the compression of the 
layer, a solid lipid monolayer is obtained (a). The lipid monolayer is then transferred on a solid 
support moved through the solution with constant lifting speed (b). A second lipid layer is 
obtained with the subsequent immersion of the support (c). 
 
 
Using LB, it is possible to obtain mainly three types of membranes (X, Y, 
Z). Repeating immersion (downstroke movement) and emersion (upstroke 
movement) of the substrate Y-type membranes are obtained; by 
downstroke and upstroke movement only, it is possible to obtain X and Z 
structures respectively (Fig. 3.8).  
 
 
 
Figure 3.8. Three possible lipid membrane configuration. The Y-type represent the typical 
lipid bilayer, in which the hydrophobic tails of one monolayer are in contact with the tails of 
another one. The X and Z type are characterized by the formation of stacked lipid monolayers 
in which lipid head groups are in contact with the tails of another monolayer. 
 
2. Langmuir-Schaefer (LS). LS was introduced in 1938 and consists in 
the preparation of a solid lipid layer on the air-water interface, as 
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already described for LB, but the deposition on the solid support is 
horizontal. In particular, the solid substrate is approached at low speed 
toward the lipid monolayer (2-4 mm min-1) and, after contact, lifted up 
(1-2 mm min-1). In this way, X-type films are prepared (Fig. 3.9). 
 
 
Figure 3.9. Schematic representation of Langmuir- Schaefer deposition. X-type lipid layers 
are easily prepared by subsequent approaches of the substrate to a lipid solid layer formed at 
air-water interface. 
 
 
3. Fusion of vesicles. It is one of the most popular method for the 
preparation of lipid bilayers on a solid support. After the preparation of 
SUVs in solution, they are put in contact with a flat surface where the 
rupture of the vesicle occurs. The fusion of vesicles on the surface is 
affected by the lipid composition, size, surface characteristics, pH, and 
ionic strength 174. The mechanism is not completely understood but it is 
known that the process involves adsorption of the vesicles on the 
surface, deformation, flattening and rupture to form a continuous SLB  
(Fig. 3.10).  
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Figure 3.10. Cartoon depicting fusion of SUVs on a solid substrate. 
 
The main advantage of this technique is the simplicity of this approach, 
although compared to LB, it is impossible to control the lateral pressure 
and to prepare asymmetric bilayers.  
 
 
4. Spreading of organic solution. A solution of lipids, dissolved in a 
solvent are directly pipetted on a solid support and let to evaporate 
favouring the self-assembly of the molecules (Fig. 3.11). The main 
advantage of this approach is that it does not require any 
instrumentation, is easy and fast to perform 175,176.  
 
 
 
Figure 3.11.  The picture depicts the deposition process of lipids by solution spreading. A 
syringe is used to deposit a drop of organic lipids’ solution at the center of a silicon wafer. 
From Seul et al, 1990 175. 
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It is used especially for structural studies by NMR or X-ray scattering 
because of the multilamellar characteristics of the membrane obtained, 
impossible to prepare with the previously described techniques but, at 
the same time, it is difficult to control the exact number of layers 
forming. 
 
5. Spin coating. In this case, lipid dissolved in organic solution are 
deposited on a supported substrate (hydrophilic or hydrophobic) and 
accelerated to rotation using a spin coater 177 (Fig. 3.12). Thanks to the 
centrifugal forces, after the evaporation of the solvent a homogeneous 
film of well-oriented lipids is deposited on the surface.  
 
 
 
Figure 3.12. Sketch illustrating the spin-coating procedure showing a pipet with lipid solution 
above the rotating substrate. Adapted from Mennicke et al, 2002 177 
 
 
3.2.1 Artificial Lipid bilayers: a model for lipid rafts 
 
Artificial membranes are simple systems that allow easy control of the 
experimental conditions and are extremely useful to investigate the principles at 
the basis of membrane organization. SLBs are commonly used as model system 
in order to study biological membranes. The main advantage of this approach is 
the stability of the membrane, the possibility to prepare membranes with 
different lipid composition and the availability of an easy protocol for the 
deposition. The alternative is the study of vesicles in solution, especially GUVs, 
having dimension from few to hundreds of micrometers, which can be studied 
with conventional optical microscopes.  In presence of a lipid composition 
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mimicking rafts, a spontaneous organization into domains occurs. These 
domains are rich in sphingolipids and cholesterol (Lo phase), distinct from a 
more disordered phase (Ld). These model systems have been characterized with 
different techniques. Among them, Fluorescence Correlation Spectroscopy 
(FCS) and Fluorescence Recovery After Photobleaching (FRAP) were used to 
distinguish the two phases, based on  fluidity differences, in SLBs 178,179 and 
GUVs 180,181. These approaches were used also to calculate the diffusion 
coefficient, the effect of saturation in the acyl chains, cholesterol concentration, 
and dynamics. From the other hand, SLBs were used to evaluate the effect of 
the presence of proteins on the lipid lateral mobility and phase transition 
temperature 182–185. Recently, the combination of FCS with AFM 
measurements, allowed the characterization both of dynamic characteristics and 
morphological organization at the same time 186. A combination of FCS and 
STimulated Emission Depletion microscopy (STED) was also used to 
investigate the dimension and the dynamic properties of raft-like domains 187. 
AFM measurements have been used to characterize topology of rafts and the 
difference in height of ordered domains, which, depending on the cholesterol 
content, are around 0.5-1 nm higher 188,189, giving a precise three dimensional 
characterization of these structures at nanometer scale. Wide-angle X-ray 
diffraction (WAXRD) was used to characterize the thickness of lipid domains 
in multilamellar vesicles composed by DOPC/sphyngomielin, resulting in an 
increase in the height of 0.9-1.1 nm respect to DOPC only 190. Moreover, 
Single-Particle Tracking (SPT) was used to analyse the lipid diffusion inside 
rafts. In this case, some lipid molecules are bound to a gold nanoparticle and, it 
is possible to follow the particle movements inside the layer using confocal 
laser microscopy. In this experiments the coefficient of lipids inside the Lo 
phase was demonstrated to be similar (0.38 x 10-8cm-2 s-1 ) than in the Ld phase 
(1.1 x 10-8cm-2 s-1) 179. 
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4. Results: AS immobilization on a gold surface 
 
The unfolded characteristics of IDPs and their propensity to aggregate make 
difficult to study them with conventional, solution based techniques. In 
particular, the determination of binding affinity parameters is a challenge and 
no data are available in literature. In this context, techniques based on protein 
immobilization on surfaces can be a valid alternative to study biorecognition 
phenomena. In this section, preliminary experiments about the immobilization 
of AS on a gold surface by AFM nanografting and the study of the interaction 
with DA are described. 
 
4.1 via cysteine-tag a 
 
Despite the known limitation of surface studies, they can represent a good mean 
for IDPs study. Surface techniques can provide indeed important information 
about the interaction with small molecules, impossible to be measured in bulk. 
In order to immobilize in a well oriented manner AS on a gold surface, we 
decided to engineer a specific tag at the N-terminal of the protein. In particular, 
we introduced via recombinant techniques two cysteines at the N-terminus b 
through which grafting the protein on a gold film exploiting the Au-S chemistry 
(see Fig. 4.1). The N-terminal as grafting site has been chosen because in this 
way we expected to have the C-terminal of the protein free to interact with the 
solution. The acidic region of the protein contains in fact the 125YEMPS129 site 
(res 125-129) that is reported as the main binding site for DA. Scope of our 
work was to study the binding affinity of AS with this small molecule, DA, 
physiologically relevant but still unknown in literature. Exposing the 
125YEMPS129 site towards the solution, we aimed at obtaining a homogeneous 
distribution of AS orientation relatively to its grafting site. Self-assembling 
assisted by the AFM tip, as in nanografting, can represent a good method for 
the study of IDPs. In particular, AS was immobilized into a self-assembled 
                                                            
a  S. Corvaglia, B.  Sanavio, R. Enriquez, B.  Sorce, A. Bosco, D.  Scaini,  S.  Sabella, G.  Scoles,  L. 
Casalis,  Quantitative  nanoarray  for  α‐Synuclein‐dopamine  bioaffinity  interactions:  potential 
drug screening assays for intrinsically disordered proteins, SciRep, submitted 
 
b In collaboration with dr. Barbara Sorce and dr. Stefania Sabella, IIT‐Lecce, Italy 
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monolayer of alkanethiols terminated with six ethilenglycole units (EG6) that 
does not change during the experiment because of its bio-repellent properties 
and, for this reason, it is used as reference for topographic AFM measurements 
of AS functionalized patches. 
 
 
 
 
Figure 4.1. Schematic representation of the nanografting experiment. A self-assembled 
monolayer of biorepellent thiols on gold is substituted locally by cysteine-tagged AS. The 
protein on the surface expose the C-terminal that contains the specific site for DA binding 
(125YEMPS129), which overlaps for one amino acid with the site for a AS mAb (121DNEAY125). 
 
Because of the difficulty to handle unstructured proteins, the protocol of the 
immobilization required a careful review. The immobilization of AS was in fact 
never successful when it was dissolved in buffer solution where the protein is 
expected to be in the unfolded state. Besides the reduced diffusion, protein 
grafting was probably hindered by the structure of the unfolded protein, by 
which was hiding the cysteine tag engineered at the N-terminus, preventing the 
interaction between the cysteine sulfur group and the gold surface.  
Therefore, we exploited grafting buffers that favor either alpha-helical or beta-
sheet conformation. When AS was dissolved in trifluoroethanol (TFE) to force 
alpha-helics 104, the increased rigidity of the protein in correspondence of a long 
segment at the N-terminal 191 (similarly to membrane-associated AS 
conformation) did not leave the cysteine tag free to react, and the grafting was 
unsuccessful.  
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Successful immobilization was obtained only in solvents that promoted 
secondary β-sheet structure and amorphous oligomers for AS 104. We 
nanografted AS in pure methanol, with an addition of a reducing agent (TCEP) 
in millimolar concentration: the latter keeps the di-cysteine tag reduced and the 
thiols freely available to interact with gold. This result was totally unexpected, 
since in principle disulfides adsorb on gold more efficiently with respect to 
thiols. Again, we explained this result in terms of protein conformation, which 
could hinder somehow the disulfide-Au  interaction. In addition, in presence of 
TCEP, the N-terminus is negatively charged, and possible electrostatical 
repulsions with the acidic C-terminus can be another reason for the thiolated 
end staying out of the β-sheet secondary structure of the protein.  
  
 
 
Figure 4.2. The AS was nanografted in a reference thiolated EG6 SAM (a,c). The presence of 
the protein was confirmed by the loading of the mAb and a variation in height, compatible with 
the size of the mAb, was recorded (b,d). Scale bar 1 µm. 
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AS nanografting was performed in methanol scanning 1 µm x 1 µm area of the 
gold surfaces with force around 100 nN. The sample was imaged in contact 
mode at minimum force (below 100 pN) in buffer solution (Fig. 4.2).  
The AS patch appeared as a hole of height of -1.5 nm, with respect to the EG6 
carpet. To calculate the “true” height of AS molecules in the patch, we 
measured the height EG6 carpet with respect to the gold film surface, creating a 
hole in the EG6 SAM via  “nanoshaving” (i.e. nanografting in a solvent for 
EG6, methanol in our case, without any other thiolated molecules in solution). 
From the topographic profile of the hole, a height of 2.6 nm was calculated, 
compatible with EG6 dimension (Fig. 4.3).  
 
 
 
 
Figure 4.3. Nanoshaving into EG6 SAM. a) AFM topography of a hole into the EG6 SAM. b) 
Topographic line profile of the surface suggests a height of about 2.6 nm. 
 
As a consequence, AS average height in the nanostructure was about 1.3 nm. 
This is in agreement with previous reports  measured the effective radius of AS, 
assuming a spherical structure, to be 1.7-2.1 nm 192.   
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Moreover, the fact that we obtained a hole and not a protruding AS 
nanostructure may be related to the low density of the grafted molecules, due to 
the reduced mobility of AS in solution, and to the compressing effect of the tip 
during imaging, despite the extremely low load applied.  
In the experiment shown in Fig. 4.2 (from now on recalled as exp.1), the 
presence of AS grafted on the surface was also confirmed by exposing the 
surface to a specific mAb (8 nM, clone syn 211) able to recognize an epitope at 
the C-terminal of the protein (Fig. 4.2 b,d). We chose a mAb whose recognized 
epitope spans residues 121-125 (121DNEAY125) 193,194 and overlaps for one 
amino acid the region of residues 125-129 (125YEMPS129), which is known to 
be a target for DA 114, as shown schematically in Fig. 4.1. 
The differential increase in height after mAb binding is compatible with the 
average dimension of an immunoglobulin G molecule (IgG ca 15-18 nm). 
Specificity of the binding was also confirmed with a mock nanografting 
experiment. An area was “nanoshaved”, removing the preexisting SAM and 
exposing the bare gold surface. The sample was then incubated for 2 hours with 
mAb that did not bind to the selected area, except few particles, not comparable 
with the specific protein recognition (Fig. 4.4).  
 
 
 
Figure 4.4. AFM nanoshaving was performed into an EG6 thiols carpet. A hole was 
measured by contact mode AFm in liquid (left). The sample was incubated in presence of mAb 
(clone syn 211) for two hour. AFM imaging suggest no relevant variation in the shaved surface, 
meaning that no aspecific interaction with gold occurred. 
 
In order to prove further the success of AS nanografting, we observed that both 
surface roughness and friction within the nanografted area were different from 
the surrounding carpet, which is compatible with a modified surface (Fig. 4.5). 
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Figure 4.5. The image report the friction signal (difference between lateral force trace and 
retrace) for a nanopatch obtained after nanoshaving of the surface (left) and after AS 
nanografting (right). Clearly, in the first case, the friction signal is very weak and the 
nanoshaved area is almost indistinguishable while the surface functionalization is evident by an 
increase of friction. 
 
 
4.1.2 AS-DA affinity 
 
Having proved that nanografting is an effective way to immobilize AS in 
confined areas, we tested such micropatterns as sensor to study the binding 
affinity with DA. This neurotransmitter is known to interact with residues 120-
125 in the C-term tail of the protein, and simultaneously with residues in the 
NAC region as long range contact that may stabilize the bound conformation 
115,116.  
 
4.1.2.1 AS nanostructures to study DA-AS affinity 
 
In order to estimate DA-AS binding affinity, we build a binding assay, 
measuring the topographical variations of AS nanografted patches incubated 
with increasing concentration of DA.  
 
   
67 
 
 
Figure 4.6 AS-DA binding experiment. AS change morphologically and some particles 
appear after increasing DA binding, scale bar 500 nm. The loading of DA at increasing 
concentration lead an evident morphological modification of the protein.  
 
An average increase in height, though very moderate, could be recorded. More 
interestingly, the roughness of the nanografted area showed an increase, related 
to DA binding (Fig. 4.6).  
Inspection of the AFM images shows the presence of particles that do not 
increase in number (they are the same throughout the experiment) upon DA 
dosing. We analyzed the binding of DA to AS through a sigmoidal dose 
response of the patch height, obtaining an apparent dissociation constant in the 
micromolar range (Kd= 1.66 ±1.03 µM) (Fig. 4.7a). The same fitting was 
performed on the roughness variation data, confirming the same trend (Kd=1.35 
±1.57 µM) (Fig. 4.7b).  
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Figure 4.7. AS nanografted patches were incubated in presence of increasing concentrations of 
DA. The binding was recorded by an average increase in the height of the patches. Fitting with 
a Langmuir isotherm gave a Kd= 1.66 ±1.03 µM (b). The same trend is showed by roughness 
variation analysis. The Kd calculated is 1.35 ±1.57 µM (b). The error is the standard deviation 
of the average height calculated on five different patches. 
 
 
 After loading of DA, the sample was treated with nanomolar concentration of 
mAb syn211 that recognize epitope 121DNEAY125, which overlap for one amino 
acid (Y125) to the DA binding site. The height of the patches upon mAb 
loading increases, suggesting that the surface is still covered by the protein with 
the binding site exposed to the liquid-solid interface, in agreement with 
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previous studies 195. The measured height (3.3 nm over the AS nanografted 
patch) is however lower than expected (see exp. 1, Fig. 4.2 b,e) suggesting that 
only a portion of the C-terminal is exposed, probably because, upon the 
formation of AS-DA adducts, only a part of AS molecules expose the C-
terminal to the solution (Figure 4.8). 
 
 
 
 
Figure 4.8 AS-DA patches recognize the mAb. The AS nanografted patches were treated with 
10 mM DA (a). The patches where then incubated with nM concentration of the mAb (b). The 
topography of the surface increases but it is less than expected (c). 
 
 
4.1.2.2 mAb-DA non-competitive binding 
 
AS nanografted patches are recognized by mAb syn211 that binds epitope 
121DNEAY125, which overlap for one amino acid (Y125) to the binding site of 
DA. This specific mAb was chosen among many for its capacity of binding the 
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C-term chain of AS and because of the vicinity of the epitope to the DA binding 
site. In fact, though the DA binding site overlap for only one aa, there is a 
chance that the conformational change due to the short and long range 
interaction of DA with 125YEMPS129 and residues in the NAC region 
destabilizes the binding site of the mAb, as is indeed observed experimentally. 
The overlapping of only one amino acid of the bindings sites is not sufficient to 
consider the binding of DA and mAb competitive. For this reason, we called it 
as “non-competitive”. 
 
 
 
 
Figure 4.9 mAb-DA non-competitive binding. AS patches recognized by the mAb are 
incubated with increasing concentration of DA. The plot reports DA response as height 
variation over AS-mAb nanopatterns (H/H0). The displacement of the mAb is monitored as a 
decrease in height. The plot report the height variation as a function of DA concentration. 
Fitting with an inverted Langmuir isotherm gave a Kd = 3.92 ±1.64 µM.  
 
Since small molecules, like DA, need very precise instrument in order to 
register their binding, the non-competitive binding assay can confirm more 
confidently the data obtained in the direct binding assay. In this case, bigger 
height variations, relatively easy to be measured, can give more precisely the 
estimation of the binding constant.  In this assay, immobilized AS was 
incubated in presence of the mAb and the saturated surface was analyzed by 
AFM topography variations. 
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After DA addition at increasing concentration, the patches show a decrease in 
height due to the partial displacement of mAb molecules over the patch (Fig. 
4.9). 
Plotting the height signal as measured height over saturated height vs DA 
concentration, we obtain an inverted Langmuir isotherm from which it is 
possible to calculate the Kd value that represents the concentration of DA that 
displays half-maximal displacement of the mAb. The value obtained is around 4 
µM and in good agreement with the experimental Kd calculated in the direct 
assay previously described. As observed by the data plot, at saturation the mAb 
is just partially displaced by the surface. This phenomenon suggests that, during 
the conformational change that affects AS molecules, probably a part of them 
continues to expose the C-terminal to the solid-liquid interface (see previous 
experiment, Fig. 4.8). 
 
4.1.1 AS nanostructures to promote the formation of supramolecular 
assembly and to study the effect of DA on them. 
  
Finally, I present preliminary results about the potential use of this assay to 
study the early stages of the AS aggregation. In this case, AS nanografted 
patches (Fig. 4.10a) were incubated with a solution containing recombinant AS 
(histidine-tagged) to promote AS aggregation. We observed a time-dependent 
topographic height increase over the AS patches versus incubation time (24-48-
72 hours, Fig. 4.10b, c, d) suggesting a local interaction between AS molecules. 
The addition of highly concentrated DA (20 µM, close to the saturation point) 
disrupts these aggregates after 30 minutes incubation, probably stabilizing small 
oligomers, observable as round spheres by AFM imaging (Fig. 4.10e). Further 
addition of AS histidine-tagged molecules plus DA after DA treatment does not 
show any increase in patch height after 24 hours incubation, confirming the 
stable binding of DA on the protein (Fig. 4.10f). The analysis of the roughness 
of the patches confirms the formation of aggregates on the surface (Fig. 4.11b).  
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Figure 4.10. AS patches were incubated in presence of AS histidine tagged. The surface was 
monitored over time by topographic AFM measurement (a, b, c, d). Finally, the effect of DA 
was evaluated. DA interacts with the AS self-association site disrupting the aggregates formed 
in 72 hours, stabilizing small oligomers (e). Such binding is stable and prevents the self-
association in presence of AS molecules also after 24 hours of incubation (f). Scale bar 500nm. 
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 Figure. 4.11. The aggregation process and the disaggregation are reflected by the topography 
(a) and the roughness (b) of the surface. 
 
 
These data support the hypothesis that DA and its oxidation products, such as 
dopaminochrome, interacting with the 125YEMPS129 region, inhibit the 
formation of AS aggregates. This suggest that DA binding probably causes a 
conformational rearrangement in the AS molecules, due to the interaction with 
distal residues at the N-terminal, leading to an off-pathway intermediate, unable 
to produce aggregates. 
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4.2 Other strategies for AS immobilization 
 
In order to immobilize a protein we tried also other strategies but they revealed 
unsuccessful. Some of these tests are described.  
 
4.2.1 Via NTA-Ni-Histidine chemistry 
 
Another approach we used in order to immobilize the AS on a gold surface was 
via NTA chemistry. The main advantage of this approach is the possibility to 
use a histidine-tagged protein (commercially available). In this case, three NTA 
molecules are covalently bound to a DNA sequence 24 bases longc (Fig. 4.11).  
 
 
 
Figure 4.11. Schematic representation of ssDNA sequence modified with three NTA residues. 
 
In this way, the hybridization of ssDNA NAM gives a functionalized surface 
available for the protein immobilization. Another advantage of this approach is 
to have the protein far away from the surface and freely available to fold in the 
proper manner. Moreover, it is possible to have an assay that could be 
regenerated, used many times, and naturally prone to the multiplexing via DNA 
base-pairing. 
For this reason, we performed the nanografting of a thiolated ssDNA sequence, 
24 bases long (HS-F5) on a gold surface into a self-assembled monolayer of 
alkane-thiols, terminated with 3 ethilen-glicole units (HS-(CH2)11–
(OCH2CH2)3OH) used as reference carpet. The nanografting of the ss-DNA, at 
different densities (S/A from to 5.12 to 0.64) was done (Fig. 4.12). 
                                                            
c In collaboration with Dr. Lijljana Fruk, DFG- Centre for Functional Nanostructures, Karlsruhe 
Institute of Technology (KIT), Karlsruhe, Germany. 
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Figure 4.12. ssDNA nanografting into an EG3 thiols carpet at different densities (S/A =5.12, 
2.56, 1.28, 0.64). AFM topography (left) and average height of the patches (right) are reported. 
 
 
As expected, the height of the patches increases as the density of the molecule 
increases. This is because crowed standing up molecules are much more 
affected by repulsive van der Waal forces and/or electrostatic repulsion which 
let them to stretch in the unconstrained vertical direction 148. At this point, in the 
easier and fast 2 step-approach (Fig. 4.13), the conjugate between cDNA-
NTA+NiCl2+Protein was prepared in solution and then let to conjugate with the 
immobilized ssDNA. In order to optimize the technique for the deposition of 
the protein, we decided to start with the deposition of D18, a Fab (50kDa) of 
the prion protein, already used in our laboratory for the deposition via histidine-
tag on thiolated-NTA-terminated molecules 150. The complex was prepared was 
prepared in solution (600 nM F5-NTA, 1.8 µM NiCl2, 1.8 µM D18 in PBS) and 
incubated for one hour on the surface.  
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Figure 4.13. Schematic representation of protein immobilization via NTA-Ni(II)-Histidine 
in two steps. After the nanografting of ssDNA sequence, the hybridization of the complex 
(cDNA-NTA +Ni(II) +Protein) can be performed. 
 
The measurement of the topography of the surface suggests a successful 
hybridization of the complex, which, as expected is strongly dependent on the 
initial ssDNA (Fig. 4.14, red bars). In fact, it occurs with higher efficiency 
when the crowing is lower while higher is the covering of the molecules, less is 
the probability the complementary strand interacts. As already mentioned, the 
surface could be easily regenerated by imidazole, which, competing with the 
histidine tag of the protein, is able to displace it. In this way, the surface expose 
the dsDNA –NTA-terminated, measuring height profiles compatible with the 
hybridized DNA (Fig. 4.14, green bars).  
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Figure 4.14. Height of the patches for D18 Fab immobilization on a gold surface with NTA 
strategy. Nanografting of ssDNA was performed at different S/A (from 5.12 to 0.64) and the 
height recorded reflects the density of the molecules (blue bars). The hybridization of the D18 
complex was more efficient when DNA molecules are less dense (S/A=1.28 and 0.64). Finally, 
imidazole, competing with histidine, removed the protein (green bar). 
 
The same approach was tried for the immobilization of AS, but no 
hybridization occurs. We speculated that DNA sequences in solution interact 
aspecifically with the protein an hence is not able to hybridize the 
complementary DNA.  
For this reason, a second strategy was used. In this case, the reaction was 
performed step by step (Fig. 4.15).  
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Figure 4.15. Schematic representation of protein immobilization via NTA-Ni(II)-Histidine 
in three steps. After the nanografting of ssDNA sequence, the hybridization of the complex 
(cDNA-NTA) lead to a functionalized NTA surface. Finally, after loading of Ni(II) the protein 
is immobilized. 
 
 
First, the nanografted thiolaed ssDNA was let to hybridize with its 
complementary strand NTA-conjugated and the variation in the topography of 
the patches was measured. Then, the surface was activated by the Ni2+ chelation 
and finally AS was added (Fig. 4.16).   
Unfortunately, also in this case the immobilization did not occur. Probably, as 
observed for the direct nanografting also (see chapter 4.1), the conformation of 
AS in acqueous solution, expected to be unfolded, easily could hide the tag at 
the N-terminal (histidine-tag in this case) decreasing the efficiency of the 
immobilization.  
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Figure 4.16. NTA-Histine tagged AS immobilization by nanografting. Nanografting of 
thiolated ss DNA 24 bases was performed into an EG3 SAM. The sample was then hybridized 
by the complementary DNA strand modified with NTA. Finally, after Ni (II) loading, histidine 
tagged AS was added but no variation in height was found.   
 
 
4.2.2 Amine-coupling 
 
The immobilization of proteins through the covalent binding to a carboxyl-
functionalized gold surface was also exploited. For example, Potassium/sodium 
hyperpolarization-activated cyclic nucleotide-gated channel 4 (HCN4) 196 was 
immobilized with this strategy d. First, a self-assembled monolayer (SAM) of a 
thiolated carboxylic acid (16-mercaptoesadecanoic acid, HS-(CH2)15-COOH) 
was growth on a flat gold surface and the formation of the SAM was confermed 
by “nanoshaving” AFM measurements. The height of the layer on gold is 
around 1.8 nm, compatible with the dimension of the molecule.  Second, 
carboxylic groups were activated through the reaction with DCC and NHS, as 
described in chapter 2, and the protein was incubated for 1 hour. Also in this 
case “nanoshaving” was used in order to confirm the reaction with the protein. 
The variation in this case is of few nanometers and some particles are observed, 
                                                            
d In collaboration with Prof. Vincent Torre, SISSA, Trieste. 
   
80 
 
compatible with the partial aggregation of the protein and the formation of the 
tetramer (Fig. 4.17). 
 
  
                 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17. AFM imaging in contact mode and relative topographic profile of Amine-coupling 
process for the immobilization of HCN4. A SAM of a 16-mercaptoesadecanoic acid has been 
formed on a flat gold surface. The nanoshaving of the SAM gave the height of the layer (upper 
images). Appling the amine-coupling protocol the immobilization of the protein was measured 
as a height increase (bottom images).  
 
The same protocol was used for the immobilization of AS. In this case, 
nanografting of the thiolated carboxylic acid was performed and topography of 
the patches measured (Fig. 4.18). The height of the NAM in this case is around 
2 nm, higher than in the SAM of the previous experiment, meaning a major 
order and packing of the molecules. 
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Figure 4.18. Nanografting of 16-mercaptoesadecanoic acid into an EG3 thiols SAM. The 
height of the patch is around 2 nm. 
Following the same protocol, unfortunately no AS immobilization occurred also 
in this case. This result strengthens the hypothesis that the unfolded 
conformation of AS, expected in aqueous solutions, and its high flexibility hide 
the binding site, decreasing the efficiency of the immobilization. 
 
4.3 Discussion and conclusions 
 
In this work, we demonstrated that nanografting is a useful tool to immobilize 
AS and study the interactions that affect this protein. First, we exploited 
different approaches in order to immobilize AS. We tried to immobilize 
histidine tagged protein on a DNA-NTA functionalised surface by nanografting 
but although we proved that our protocol was efficient for the immobilization of 
other proteins (e.g. D18, PrP Fab), it was unsuccessful for AS. Moreover, 
amine-coupling was exploited with the same unsuccessful rate. Finally, the 
direct immobilization of AS through a cysteine tag engineered at the N-
terminus was investigated. Also in this case the immobilization was really 
tricky, probably because, due to the unfolded state of the protein, the binding 
site could not be exposed to bind efficiently the gold surface. The only case in 
which the immobilization was successful was forcing the beta sheet 
conformation of the protein in which probably the C-terminus is free to react. 
Unfortunately, it is difficult by only AFM imaging to understand the precise 
conformation and state of AS but, referring to data in literature, small beta 
enriched oligomers are expected in solutions containing methanol 104. In order 
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to study the binding affinity, the nanografted protein was then incubated with 
increasing concentrations of DA and imaged in liquid. The orientation of the 
molecules on a confined surface and the high precision of AFM allowed the 
measurement of height and roughness variations that can be attributed to a 
conformation rearrangement of AS molecules after DA binding. This matter is 
still debated in literature. Previous CD studies suggested that DA-treated AS in 
fact changes its structure toward mostly random coiled with little alpha helices 
or beta pleated sheets structure, while FTIR spectrometry showed beta pleated 
sheets structure only 114. Therefore, further investigation are needed. Anyhow 
from our assay, exploiting these supposed conformational changes, we were 
able to calculate for the first time the dissociation constant between AS and DA, 
that is in the micromolar range. Such result was obtained both from a direct 
assay, i.e. DA binding over AS nanostructures, and from an indirect assay, what 
we called a “non-competitive” binding of DA over mAb covered AS patches. 
We showed in fact that DA was able to partially displace the mAb (syn clone 
211). The overlapping of the binding sites for one amino acid only and the 
higher affinity for the antibody (typically nM for IgG) in principle could not be 
sufficient to displace the antibody. For this reason, we called this assay non-
competitive. Our observation validated the hypothesis of a strong 
rearrangement in the three dimensional structure of the protein due to effective 
interaction of DA on the expected binding site 125YEMPS129 and to long-range 
interactions. Such structural variation led to the partial displacement of the mAb 
from its binding site. At saturation, a portion of mAb was still bound to the 
protein, probably because some C-terminals, not involved into the 
conformatonal change due to DA binding, were still exposed to the solid-liquid 
interface because not involved into the conformational change due to DA 
binding (data confirmed by the inverse experiment). This non-competitive 
binding assay gave us the possibility to measure the displacement of the mAb 
after loading of DA with more precision with respect to the direct assay,  
because of the quite large height variation signal, relatively easy to detect. This 
assay confirmed the micromolar dissociation constant calculated in the direct 
assay, supporting the validity and the precision of this technique for binding 
studies of small molecules. Finally we presented preliminary results about the 
use of our assay to study the supramolecular assembly of AS. The incubation of 
nanografted AS in presence of AS-histidine tagged molecules allowed to follow 
the growth vs. time of aggregates that are then dissolved by DA. The use of 
histidine-tagged AS, cheaper and easier available than wild type, leaves some 
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doubts. It is in fact possible that the histidine tag interacts with the acidic end of 
the AS through attractive electrostatic interactions. Our speculation, as 
suggested by previous experiments, is that the histidine tag is hidden by the 
protein structure in buffer solution and therefore not available for binding. 
However, further investigation are needed to clarify this aspect. 
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5. Results: supported lipid bilayers, a method to 
study AS interactions e 
 
In the second part of my project, I focused on the study of supported lipid 
bilayer and in particular, I was interested in the development of a model 
membrane able to mimic the lipid rafts domains of the cell. The existence of 
lipid microdomains that differ from the other areas of the membrane for their 
lipid composition is object of strong research and debate. The enrichment of 
these domains of sphingolipids and cholesterol was demonstrated. The first 
evidence comes from the analysis of the membrane domains resistant to cold 
non-ionic detergent extraction from MDCK cells, which suggested the presence 
of  Sphingolipids /Chol/glycerophospholipids in molar ratio close to 1:1:1 197. 
This cholesterol concentration induces a phase separation into 
Sphingolipids/Chol enriched domains in a Lo phase, surrounded by a Ld matrix 
formed by unsaturated species. Among sphingolipids, natural sphingomyelin 
(SM) is the most abundant and offers the peculiarity to undergo very broad gel 
to liquid crystal phase transitions. 
The human brain is particularly enriched in cholesterol and cholesterol 
derivates (>25% of total lipid content) 198. For this reason, the function of lipid 
rafts in the central nervous system (CNS) could be critical.  Lipid rafts has been 
identified in both neuronal and glial cells and a role in the neuronal signalling, 
neuronal cell adhesion and axon guidance has been suggested 199–202. Moreover, 
the presence of ionotropic receptors and neurotransmitter transporters at lipid 
rafts level suggests a role in neurotransmission 203. 
For these reasons, we used a three components system as the simplest method 
for the reconstruction of the phase separation of biological membranes: an 
unsaturated phospholipid represented by dioleoylphosphatidylcholine (DOPC), 
a saturated phospholipid represented by sphingomyelin (SM), and Chol (Fig. 
5.1). At room temperature, SM is in the gel So phase, whereas DOPC is already 
in the fluid Ld phase at temperatures above -20 °C. 
 
                                                            
e  S.  Corvaglia,  D.  Scaini,  L.  Casalis,  “Alpha‐synuclein‐artificial  lipid  bilayer  interaction”,  in 
preparation. 
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Figure 5.1. Chemical structure of DOPC, SM and cholesterol. 
  
 
A tentative phase diagram at room temperature of this ternary mixture is present 
in literature 204.   
Unfortunately the boundaries that divide the different phase states are not 
accurate and are used as a rough guide for the determination of the phase 
separation. In our case, equimolar concentration of DOPC and SM have been 
used, while the concentration of cholesterol has been modulated in order to 
enhance the phase transition. Therefore, moving along the vertical axis of the 
triangular DOPC/SM/Chol phase diagram (straight blue line on the tertiary 
phase diagram, Fig. 5.2), it is possible to observe as at room temperature and 
low cholesterol concentration, a phase separation between Ld and So phase 
occurs. Increasing gradually the concentration, there is a transition state in 
which three phases coexists (Ld-So-Lo). At cholesterol concentrations between 
roughly 8-35% a phase separation Ld-Lo has been observed whereas at 
concentrations higher than 35% the only Lo phase is present. The solubility of 
cholesterol has been found to be 66-67 % mol, therefore above this 
concentration (Fig. 5.2, hatched region of the graph) cholesterol precipitates. 
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Figure 5.2. DOPC/SM/Chol phase diagram obtained at room temperature from data in 
literature. Modulating the concentration of the three components, different phases have been 
observed. The blue straight line represents equimolar concentrations of DOPC/SM while 
cholesterol concentration increases moving toward the summit of the triangular diagram. The 
coloured regions delimit phases transitions. Adapted from Bezlyepkina et al, 2013 204 
 
In order to elucidate the characteristics of the different lipid phases as a 
function of cholesterol concentration further investigations were needed. 
First, I produced supported lipid bilayers by solvent spreading, a very simple 
method extremely useful in the preparation of multi-component membranes. 
Second, I characterized the effect of cholesterol and water (hydration) on the 
organization of the lipid phases by both AFM imaging and GISAXS 
measurements. Finally, I present preliminary results about the interaction of AS 
with this flat supported lipid bilayers in order to understand the effect of the 
lipid phase without the influence of the membrane curvature and the lipid acid 
charge. 
 
5.1 Supported lipid bilayers: characterization 
 
5.1.1 Method of deposition 
 
As described in the previous chapter, the easiest way to produce SLBs is the 
spreading of an organic solution of lipids on a solid support, leading the 
evaporation of solvent and the self-assembly of lipid bilayer when samples are 
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exposed to ambient humidity. This method is strongly affected by the 
conditions in which the evaporation occurs and, therefore, extremely high 
attention is needed during the deposition procedure. For example, if the 
temperature and the humidity were not controlled thoroughly, their variation 
might influence the evaporation rate of the solvent and, as a consequence, the 
assembly of the lipid layer. In particular, if the evaporation occurs too rapidly, 
the molecules do not have time to assembly correctly and the bilayer does not 
form, as verified experimentally. To give an instance, if a solution of DOPC 
dissolved in chloroform is immediately dried under a stream of nitrogen, the 
surface appears dirty and covered by molecules adhering aspecifically (Fig. 5.3, 
left). To avoid this problem, the use of high boiling point solvents (e.g. decane 
BP ~173°C) could help the self-assembly, decreasing the evaporation rate (Fig. 
5.3, right). 
 
 
 
Figure 5.3. AFM non-contact imaging of DOPC on mica surface in air. a) DOPC dissolved 
in chloroform was immediately dried under a stream of nitrogen and the surface appears as 
dirty. b) DOPC dissolved in chloroform:decane 2:1 was left to evaporate slowly at 30 °C in 
high humidity chamber (80% humidity). 
 
Another important factor is the humidity, which helps the assembly and packing 
of the molecules. Phospholipids are in fact composed by a hydrophilic head 
group and hydrophobic chains, which spontaneously organize into bilayers in 
order to hide the hydrophobic core and expose the hydrophilic groups to the 
surrounding aqueous layer. Therefore, hydration in high humidity chamber 
(~80% humidity) improves the quality of the layer (Fig.5.3). Further evidences 
are described in the following sections. 
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5.1.2 Role of water 
 
After a first characterization of the membrane in air, we moved to image lipid 
bilayers in a buffer solution at physiological pH (10 mM HEPES at pH 7.4). As 
soon as the evaporation of the solvent was completed (T~30 °C), with no 
hydration step, the sample was mounted in a liquid cell and characterized by 
AFM imaging in buffer solution. The behaviour of the lipid phases was 
followed in real-time collecting topographic measurements every 10 minutes. 
When DOPC/SM (1:1) bilayers, supported on a freshly cleaved mica foil, were 
imaged in tapping mode, protruding flat domains of varying size have been 
visualized (Fig. 5.4).  
In particular, immediately after the preparation, the sample shows, 
unexpectedly, the clear separation into three phases, represented by domains 
characterized by three different height, measured over the mica substrate (Fig. 
5.4):  
A. one about 4.2 nm that increase in height during the experiment until 
about 5.4 nm; 
B. another of about 3.6 nm that increase in height during the experiment 
until 4 nm; 
C. one of 1.8 nm that increase in height till becoming visible as small 
defects and disappearing after 30 minutes of imaging 
 
Regarding phase B and C, we speculated that some lipid molecules immediately 
after the deposition were not well packed. 
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Figure 5.4. AFM topography of DOPC/SM 1:1 performed in tapping mode in Hepes 10 
mM, pH 7.4. The sample, prepared without hydration step was immediately immersed in liquid 
cell and imaged during time. Clearly, lipid phases characterized by different height have been 
observed (A,B,C). During time, smaller domains fuse together forming larger ones. 
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This is confirmed by the increase in the height of the phases during the 
experiment, until they merge into one single phase (around 4 nm), compatible 
with the height of Ld phase, represented by DOPC molecules (Fig. 5.5, blue 
circles). Same behaviour for the highest phase (A), which increases in height of 
around 1 nm during the experiment till reaching 5.4 nm, value compatible with 
the So phase (Fig. 5.5, red circles). The water has therefore a strong role in 
regulating the correct self-organization of the bilayer driving lipid order.  
 
 
 
Figure 5.5. DOPC/SM 1:1. Freshly prepared samples were incubated in liquid (Hepes 10 mM) 
and real time imaged. The membrane showed phase separation and the height, calculated 
respect to the mica support, is reported. 
 
 
Moreover, the gradual disappearance of domains smaller in diameter has been 
observed over time by AFM. It is clear that the smaller domains shrink and 
disappear, probably because they merge into larger domains during time.  
For this reason, all the samples were prepared into a chamber at 30 °C and high 
humidity (80% humidity). The overnight hydration in fact avoids the presence 
of defects favouring the order of the molecules (Fig. 5.6) 
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Figure 5.6. DOPC/SM after overnight hydration in humidity chamber. The phase 
separation into two domain occurs without defects. AFM tapping mode imaging was performed 
in Hepes 10 mM immediately after the immersion of the sample in liquid. The detail in figure 
shows So domains higher 1.2 nm higher than the surrounding Ld bilayer.  
 
5.1.3 Role of cholesterol 
 
Cholesterol is an important component of the cell membrane. As reported 
above, it is fundamental for the stability of the membrane and is one of the main 
components of the cell membrane. After the optimization of the method for the 
deposition of supported lipid bilayers, we characterized our system by Force 
Modulation AFM measurements. With this approach, it is possible to 
characterize both the topography and the rigidity/stiffness of the system under 
investigation.  
In particular, we produced two samples one composed by DOPC/SM in the 
same molar ratio and the other in which cholesterol has been added with the 
same concentration as the other two components in order to obtain a Lo phase. 
Images obtained for these two systems are reported in the following figure (Fig. 
5.7). 
Topographic AFM image showed phase separation in both the experiments 
(Fig. 5.7 a,b). Overlapping FMM-amplitude signal, representative of substrate 
stiffness (see chapter 2.1.2.1) to topography, it is possible to correlate that the 
higher is the domain, the higher is the stiffness. In other words, Ld domains, 
having a higher structural disorder, are lower in height than So and Lo phases. 
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Figure 5.7.AFM FMM have been performed on DOPC/SM (left) and DOPC/SM/Chol 
(right) in the same molar ratio in air. The figure reports the topographic AFM image and the 
amplitude FMM signal in both cases. Overlapping the two signal is clear that with and without 
cholesterol, higher is the phase higher is the Amplitude signal and therefore the stiffness of the 
domain. Scale bar 1 µm. 
 
In the first sample, composed by DOPC/SM only, we expect a phase separation 
between Ld phase represented by DOPC and So phase by SM (see ternary phase 
diagram, Fig. 5.2). In this case, the height of the So phase is higher that the 
surrounding Ld phase. In presence of cholesterol instead, the separation between 
a Ld and a Lo phase is expected. The information about the rigidity of the 
domains of the bilayer have been extrapolated as current variation (higher 
signal, higher is the stiffness) normalized on a reference substrate, in our case 
mica, recorded by a scratch on the surface. The following plot has been 
obtained (Fig. 5.8).  
 
   
93 
 
 
Figure 5.8. AFM-FMM amplitude signals normalized over the mica substrate for 
DOPC/SM and DOPC/SM/Chol in the same molar ratio. In both cases, the first signal 
represent the shorter domain, the second to the higher. According to the three components phase 
diagram, possible corresponding phase is reported.  
 
From the graph, it is possible to observe qualitatively as in absence of 
cholesterol the two phases (Ld-So) had a slight difference in the stiffness, that is 
moderately larger for the highest So phase. In presence of cholesterol, both 
phases show a stiffness increase compared to the samples without cholesterol. 
Therefore, at this concentration cholesterol has a preferential accumulation in 
the Lo phase although a portion of molecules enriches also the fluid phase 
increasing its rigidity.  
Moreover, AFM measurements (tapping mode, air) have been used in order to 
characterize the height of the domains of DOPC/SM plus different cholesterol 
concentrations. The following graph, reporting the difference in height between 
the higher and the shorter phases, summarizes the results (Fig. 5.9). 
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Figure 5.9. Difference in height between the lipid phases obtained from DOPC/SM plus 
various percentage of cholesterol. The trend is that increasing cholesterol concentration, a 
decrease in the difference in height is observed. These data support the previous experiment and 
a cholesterol effect on the Ld phase could be speculated. At 5% cholesterol three phase have 
been observed. Height values were calculated as difference referring to the higher phase.  
 
These data supports the previous FMM measurements. In fact, we can observe 
as the difference in height between the domains of the membrane has a slight 
decrease increasing the cholesterol content. Our speculation is that at high 
concentration cholesterol stabilizes also the Ld phase, increasing the packing of 
molecules and, as a consequence, the height of the layer and its rigidity. 
Notably, at 5% cholesterol, the coexistence of three phases have been observed, 
probably because in this regime we are exploiting the transition region in the 
phase diagram. Summarizing, the position of the measures, cholesterol enriched 
lipid phases in DOPC/SM/Chol phase diagram has been speculated and 
reported in Fig. 5.10. 
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Figure 5.10. The phase diagram reports the experimental points characterized by AFM 
topography of DOPC:SM 1:1 varying cholesterol concentration. When cholesterol is not 
present is the lipid mixture, Ld-So phase separation has been speculated whereas at 
5%cholesterol three phases have been observed. At higher concentrations (10-20-33% mol 
Chol) only Lo-Ld phases are present. 
 
5.1.4 AFM characterization in liquid 
 
Although we demonstrated that the careful control of hydration allows for the 
formation of well ordered lipid phases, we moved toward the characterization 
of our model system in liquid with the final aim to study the system more close 
to the physiological environment. Supported lipid bilayers with different lipid 
composition were produced and characterized in topography, in liquid (buffer 
Hepes 10 mM, pH 7.4), with the aim to confidently assigning each domain to a 
certain height value. The values obtained are summarized in table 5.1. 
 
Composition (molar ratio) 
Phase A 
Height, nm 
Phase B 
Height, nm 
SM - 5.6 ±0.4 
SM/CHOL 1:1 - 6.35 ±0.2 
DOPC/SM 1:1 4.5 ±0.5 5.6 ±0.2 
DOPC/SM/CHOL 1:1:1 4.92 ±0.4 6.10 ±0.3 
 
Table 5.1. AFM height of lipid domains with different composition. The data are calculated 
from tapping-mode images performed in liquid (Hepes 10 mM). The values have been obtained 
measuring the height of lipid domain of membranes with different composition over the mica 
support. The error was calculated as the standard deviation of average value obtained from five 
different samples. 
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From the values reported in the table, we can see for example that in the case of 
the presence of SM only, when simple So phase is expected, we obtain a value 
of height, around 5.7 nm. In the case of DOPC/SM sample, we have two 
phases, one with the same So phase height, attributable then to phase-separated 
SM domains,  the other, lower in height (4.5 ±0.5), assignable to the DOPC 
domains. Similarly, in the case of SM/Chol we measure a single domain of 
height ~6.3 nm, corresponding to a Lo phase.  In the case of the 
DOPC/SM/Chol sample we measure two phases, one with similar height of the 
SM/Chol phase, the other slightly higher (4.9 nm) than the DOPC phase 
measured in DOPC/SM lipid mixtures (4.5 nm). Such height increase, also 
observed from analogous measurements in air, can be attributed to the presence 
of cholesterol also in the DOPC phase. 
 
5.1.5 GISAXS measurements and humidity-cholesterol effect 
 
Grazing Incidence Small-angle X-ray scattering (GISAXS) is a versatile tool 
emerged in the last years for the study of micro and nano-structured thin film 
and surfaces able to give information about shape and electron density of the 
sample. For this reason, it is an excellent complement to AFM measurements 
for the study of lipid bilayers. 
The geometry of a typical GISAXS experiment is illustrated in Figure. A 
monochromatic x-ray beam (in our case with an energy of 8keV) with 
wavevector ki is directed on a surface with a very small incident angle αi with 
respect to the surface. The Cartesian z-axis is the normal to the surface plane, 
the x-axis is the direction along the surface parallel to the beam and the y-axis 
perpendicular to it (Fig. 5.11). After the interaction with the sample, the 
scattered x-rays, with outgoing wavevector kf, are collected by a detector. The 
dimension of the latter determines the maximum measurable angle of the 
scattered beam. The difference between ki and kf defines the so called scattering 
vector q 205: 
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Figure 5.11schematic representation of a GISAXS experiment. The incoming x-ray beam 
propgates along the wavevector ki at small angle αi with respect to the sample axes. After 
scattering the outgoing beam, with wavevector kf, is collected by the detector. 
 
In the case under study, lipid bilayers, the GISAXS signature is formed by 
stripes at regular spacing along the qz direction. In Langmuir-Blodgett films, 
such stripes in the diffuse reflectivity are referred to as Bragg sheets. 
In order to better understand the role of cholesterol and humidity on our model 
system, we performed GISAXS measurements at the SAXS-beamline at 
ELETTRA-Synchrotron light source.  
In particular, we used this method to investigate the structural transition of 
DOPC/SM multi-bilayer in presence of a different percentage of cholesterol 
(here we present the results relative to 10% cholesterol) at different bilayer’s 
hydration levels by changing the relative humidity (from 5% to 85% to 5%). 
For each experiment, we performed 60 independent measurements, 15 seconds 
reading, with a time interval of 2.5 minutes. Supported lipid bilayers have been 
prepared on silicon wafers by solvent spreading at 30 °C and 80% humidity 
chamber. After the complete solvent evaporation and hydration in order to 
enhance the order and packing of the molecules, the samples have been put in a 
vacuum chamber in order to remove completely the solvent residues, which 
could interfere with the GISAXS measurements.  
Here the example of DOPC/SM +10% cholesterol. The following plot reports, 
in a colour scale, the variation of the scattered intensity as a function of the 
scattering vector q and the relative humidity (Fig. 5.12).  
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Figure 5.12. The following plot reports, in a colour scale, the variation of the scattered intensity 
as a function of the scattering vector q and the relative humidity. A and B represent the Bragg’s 
peaks of Lo and Ld phases respectively 
 
Bragg’s peaks typical of a parallel lamellar structures were observed 206. In 
general, we observe two different series of Bragg’s peaks. In general, we 
observe two different series of Bragg’s peaks corresponding to two distinct 
ordered phases (A1-A4, Lo and B1-B4, Ld). As a function of the humidity, the 
two phases change height and internal order thus changing the GISAXS spectra 
(Fig.5.11). Specifically, the number of orders of diffraction is indication of the 
packing and the order of the lipid bilayer. We note here that the spectra are 
reversible as a function of humidity although after a complete cycle the A lines 
at orders higher than 1 split into two main components. At the moment, this 
behaviour has not been completely understood and further investigations are 
required.  
In order to better understand the behaviour of lipid bilayers as a function of the 
humidity we plot two different scattering profiles vs q at high and low humidity 
(Fig. 5.13). At high humidity the fourth order is evident for the two phases (Fig. 
5.12, A1-A4 and B1-B4 peaks, blue curve), whereas at low humidity, the Lo 
phase only appears at the fourth order (A1-A4 peaks, red curve). 
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Figure 5.13. The plot reports the scattered intensity vs q, recorded for DOPC/SM + 10% 
chol. The red plot has been recorded at low humidity (~5%) whereas the blue curve at high 
humidity (~85%). A and B represent the Bragg’s peaks of Lo and Ld phases respectively.  
 
 
In order to better understand these changes, we try to fit the single spectra (Fig 
5.13) with Lorentian’s function: 
 
 
      
 
Where I0 is the background, I is the maximum intensity of the peak, q0 is the 
center of the peak and γ the half-width of the peak at half-maximum. 
From q0 we can easily compute the corresponding height of the lipid bilayer 
using the following equation: 
 
 
where n is the order of the maximum. 
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In each experiment, the fitting of the GISAXS spectra was performed on the 
first order of diffraction and the height values have been calculated. The 
following plot reports the height values of the sample with 10% cholesterol and 
the humidity variation during the experiment (Fig. 5.14, green curve). In this 
case, two heights are present, corresponding to the two lipid phases. In 
particular, Lo phase and Ld phase is expected, as discussed above. The height 
values at the maximum humidity value are 5.7 nm for Lo phase (Fig. 5.14 red 
points) and 5.1 for Ld (Fig. 5.14 blue points), in good agreement with previous 
AFM measurements. 
 
 
 
 
Figure 5.14. The plot reports the height variation of the two phases of DOPC/SM +10% Chol 
(red and blue crosses) as a function of the humidity variation during the experiment (green line). 
 
From these results, it is interesting to observe the effect of humidity on the 
height of the two main phases of the membrane, which reflects the structure and 
the packing of the molecules. Moreover, the effect seems to affect much more 
the shorter (Ld) than the higher phase (Lo), probably because the disordered 
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fluid phase has more defects, a lower content of cholesterol and rigidity than the 
ordered one; the combination of these effects probably favours the insertion of 
water molecules. It is clear from the graph that high humidity enhances the 
packing of the disordered layer while the height of the ordered one is almost 
unchanged. Notably, the effect of the humidity is reversible and the height of 
the Ld phase return perfectly to the initial values after the reduction of the 
humidity.  
Moreover, the electron density distribution of the bilayer has been calculated. 
The electron density distribution of a bilayer has maxima in the headgroup 
regions and a minimum at the methyl terminus of the hydrocarbon-chains (Fig. 
5.15a). The electron density function can be computed only if the 
measurements present four or more orders of diffraction. In this way, using an 
inverse Fourier-transformation, one can distinguish among the different parts of 
the lipid bilayer. In particular, it is possible to decompose the lipid bilayer d-
spacing into the different structural components such as the phosphate to 
phosphate distance (dpp), the water layer dimension (dw) and the monolayer 
thickness (d/2) (Fig. 5.15b). 
 
 
 
 
Figure 5.15.  GISAXS electron density function. a) the electron density function of a 
supported lipid bilayer shows maxima in the headgroup regions and a minimum at the methyl 
terminus of the hydrocarbon-chains. b) therefore, from the graph obtained, it is possible to 
calculate the dimension of the lipid bilayer (d), phosphate to phosphate distance (dpp) and the 
water layer thickness (dw). Adapted from Rappolt et al, 2003 207 
 
As discussed above, the electron density function of the Ld phase was not 
calculated because of the lack of the sufficient number of order of diffraction, 
indicative of a low packing and order in the organization of lipids in the 
formation of the layer. However, at high humidity, four orders of diffraction 
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have been identified, suggesting a relevant role of water in the organization of 
the Ld phase. The Lo phase instead is not affected too much of humidity effect, 
showing a good organization of the layer also at low humidity. In the following 
graph the electron densities of Lo phase at low humidity (Fig. 5.16 red curve) 
and Lo-Ld phases at high humidity are reported (Fig. 5.16 dashed lines). 
 
 
Figure. 5.16 Electron density profile obtained from the sample composed by DOPC/SM 
+10% cholesterol. The graph has been obtained overlapping the higher phase (corresponding 
to the Lo phase) at low (hum ~5%, red line) and high humidity (hum ~85%, dashed red line). 
The blue dashed line corresponds to the Ld phase at high humidity. The lack of order for Ld 
phase at low humidity did not provide sufficient data for the calculation of the electron density 
map. 
 
For each curve, dpp, d/2 and dw have been calculated and reported in the 
following plot (Fig. 5.17)  
   
103 
 
 
 
Figure 5.17. From the electron density map it was possible to calculate the phosphate to 
phosphate distance (dpp), half of the bilayer thickness (d/2) and the thickness of the water layer 
(dw) for Lo phase at low (red blocks) and  high (pink blocks) humidity and for Ld phase at high 
humidity only (blue blocks). 
 
If we compare the values calculated for Lo phase at low and high humidity, it is 
possible to observe the increase of the thickness of all the d parameters in the 
case of high hydration. In particular, dpp, i.e. the thickness of the bilayer, 
increases (variation about 0.16 nm) meaning that water has a role in the 
organization of the lipid phase order. Moreover, the same trend is observed for 
d/2 (variation about 0.14 nm) and dw (variation about 0.1 nm) parameters, 
suggesting, as expected, an increase of the water layer thickness that covers the 
hydrophilic head groups of the layers. Unfortunately, the lack of sufficient data 
for the calculation of the electron density function for Ld phase also at low 
humidity does not allow the comparison with the high humidity values. 
However, comparing the dw of Lo and Ld phases at high humidity, we can 
observe that it is higher for Lo phase, but we do not have access to the 
information about the effect on the lipids’ structure. 
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5.2 AS-lipid membrane interactions 
Finally, the effect of AS binding on a lipid raft mimicking membrane was 
evaluated by both AFM and GISAXS measurements. In this section, 
preliminary results are described.  
5.2.1 AFM-characterization 
 
In order to evaluate the effect of AS binding to a model lipid bilayer, artificial 
lipid membrane with different lipid phases have been incubated in presence of 
AS in solution (AS 3 µM dissolved in Hepes 10 mM, pH 7.4) and the binding 
was monitored in real-time by tapping-mode AFM imaging in liquid. This 
approach permits us to visualize and study submicrometric lipidic domains. 
In the first experiment, a membrane composed by sphingomyelin only was 
prepared on a mica substrate. In this case, a So phase was expected. After a first 
characterization of the sample, a solution containing AS was incubated and the 
surface has been imaged for some hours by AFM (Fig. 5.18).  
The height of the membrane, after an initial decrease (around 1 nm after 1 hour 
AS incubation), does not show any variation and also the roughness of the 
surface of the membrane remains unchanged.  
The decrease in height (~1.1 nm), after the addition of the protein solution, is 
probably due to the aspecific adsorption of AS on the mica surface visible as 
spots on the background (Fig. 5.18). The lack of AS binding on the membrane 
surface is probably due to the organization of lipids in the bilayer. In fact for So 
phase, we have a crystalline phase that is characterized by high packing of SM 
molecules.  
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Figure 5.18. AFM topography of SM in presence of 3 µM AS. The images, collected during 
time in tapping mode, show no evident morphological variation of the membrane, while some 
molecules seems to attach on the mica substrate.  
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Figure 5.19. AFM height variation of SM membrane incubated in presence of 3 µM AS. 
The plot report the height variations measured during the experiment. 
 
In the second experiment, a sample DOPC/SM 1:1 sample, has been prepared in 
absence of cholesterol, and a phase separation So-Ld occurred. In this case, 
tubular structures have been observed after 4 hours AS incubation. Initially 
these structures are 100-200 nm in length but during time the number of fibers 
and their length increase dramatically, until became difficult to determine their 
dimension. The height over the lipid bilayer is around 0.2 nm. Finally, after 7 
hours of incubation, the number of these tubular structures is so high that is 
almost impossible to distinguish the single tubule (Fig. 5.20).   
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Figure 5.20. AFM topography of DOPC/SM 1:1 in presence of 3 µM AS. The images, 
collected during time in tapping mode, show the formation of tubular structure after 4 hours 
only on the surface of the membrane.  
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Moreover, it is interesting to consider that the formation of the tubules affects 
only the membrane whereas on the mica substrate we do not observe any 
particular structure meaning that the phenomenon is specific for the lipid 
bilayer (Fig. 5.21c).  
 
Figure 5.21. AFM topography of DOPC/SM 1:1 after 1 hour AS incubation. a) The colour 
scale underline the presence of filamentous structures on the membrane surface. b) The AFM 
topographic profile shows the height of the membrane and the dimension of the protruding 
fibers. 
 
An effect on the height of the lipid membrane has also been detected. In the 
previous experiment a decrease in the height around 1.1 nm after 7 hours was 
observed. In this case instead, a decrease of 3.3 nm has been noticed after the 
addition of AS solution. During time, the decrease is more evident until the 
shorter phase disappears and only one phase of around 3.3 nm is detectable 
(Fig. 5.22). 
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Figure 5.22. AFM height variation of DOPC/SM 1:1 membrane incubated in presence of 3 
µM AS. The plot report the height variations of the two domains measured during the 
experiment. The shorter phase is not appreciable after 5hours of incubation. 
 
Finally, another experiment has been performed in the same way on 
DOPC/SM/CHOL 1:1:1. Also in this case, a Ld-Lo occurs. Same concentration 
of protein (AS 3 µM dissolved in Hepes 10 mM, pH 7.4) was incubated and the 
sample imaged for some hours. 
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Figure 5.23. AFM topography of DOPC/SM/Chol 1:1:1 in presence of 3 µM AS. The images, 
collected during time in tapping mode, show the formation of tubular structure only on the 
surface of the membrane after 4 hours of incubation. 
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As in the previous case, filamentous structures start to associate after 4 hours of 
AS incubation and became more evident after 5 hours. Unlike the previous 
experiment, these structures do not affect all the lipid bilayer islands, their 
length does not change during time and the number also is really low. This 
phenomenon could be addressed to the presence of cholesterol that, increasing 
the rigidity and the packing of lipids, decreases the number of defects and 
probably opposes to the lodging of AS. Also in this case an effect on the lipid 
phase separation and lipid bilayer structure is evident. As in the previous 
experiment it is possible to observe a decrease in the height of the lipid bilayer 
after the addition of the protein but the progressive disappearance of the shorter 
phase until only one domain (h =2.7 nm) has been observed. 
 
 
Figure 5.24. AFM height measurements variation during the time of the two domain in 
DOPC/SM/CHOL 1:1:1 after the addition of 3 µM AS. The shorter domain, visible at the 
beginning of the experiments disappears after 1 hour of incubation. 
 
   
112 
 
The comprehension of the nature of these tubular structures and the real effect 
on the lipid phase separation is difficult to assign only based on AFM 
observation. For this reason, the use of other techniques could help in 
highlighting the phenomena. 
 
5.2.2 GISAXS measurements 
GISAXS measurements have been performed on a DOPC/SM/CHOL 1:1:1 
after incubation in presence of AS. In this case, after the preparation of the 
sample by solvent evaporation of the lipid solution, the sample was covered by 
AS 3 µM in water solution until complete evaporation. Before GISAXS 
analysis, the sample was placed in vacuum overnight in order to remove 
completely solvents residues that could interfere with the measurement. 
GISAXS is a useful tool in order to support AFM measurements because allows 
the detection of the effects on the bilayer structure and the phase separation 
without the contribution of unbound molecules that, binding aspecifically the 
mica surface, could affect the AFM height measurements.  
 
Figure 5.25. DOPC/SM/CHOL 1:1:1 after the incubation in presence of AS 3 µM. The plot 
reports the height of the two domains obtained by GISAXS measurements as a function of the 
humidity. 
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The results support previous AFM measurements confirming an effect on the 
structure of the bilayer and the lipid phase separation. Initially, at low humidity 
content, two main phases were observed, the higher (Lo) of about 5.28 nm and 
another of 4.12 nm (Ld). These heights, less than expected, support AFM 
findings. During the experiments and increasing the humidity, the height 
becomes higher for the shorter phase until it reaches the value of the higher one 
that is more stable and does not vary too much from the initial value. Finally, 
the height values become too similar (5.49-5.38 nm) to be appreciated by AFM 
topography measurements. Notably, the phenomenon is strongly dependent on 
the humidity content because the increase of the humidity favours the 
reorganization of the membrane into one phase only. 
 
5.3 Discussion and conclusions 
 
The cell membrane is one of the most important machinery of the cell and, at 
the same time extremely complex. The large number of components 
constituting a real membrane makes difficult its detailed study. In particular, 
lipid rafts, functional domains of the cell membrane, are widely studied because 
of their potential relevance in many cellular processes. For this reason, many 
biophysical studies are performed on artificial lipid bilayers. This approach 
gives the possibility to study selectively the behavior of lipid molecules, the 
basic interactions governing the formation of the membrane, and most 
importantly, protein-membrane interactions. 
In our case, we optimized a simple protocol for the formation of stable 
supported lipid bilayer by solution spreading and we studied the lipid phase 
separation. In particular, we focused on the effect of water and cholesterol in 
the lipid phase separation of DOPC and SM, among the most abundant 
phospholipids of the brain and chosen as model in order to mimic lipid rafts 
composition. First, the membranes were analyzed by AFM imaging. AFM in 
fact is a great means for the characterization of this system in the three 
dimensions with nanometer resolution both in air and in liquid environment. It 
gave the opportunity, measuring height variation, to study the behavior of the 
lipid phases and allowed to assign a specific lipid phase to each domain height 
in the different experimental conditions. My results underline the central role of 
water in the proper lipid organization to form a compact and ordered bilayer. In 
particular, we studied the effect on the two lipid phases (Lo and Ld), whose 
order and fluidity increases with hydration. Moreover we studied the effect of 
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cholesterol, one of the main constituents of the cell membrane, present naturally 
at high amount (>25% of the total lipid amount). Its function is to stabilize the 
membrane; it prefers the accumulation in the ordered phase allowing the 
development of the Lo phase characteristic of lipid rafts. AFM-FMM 
measurements gave us information about the contribution of cholesterol on the 
membrane stiffness. The results confirmed an increase in the stiffness of the Lo 
phase although, at 33 mol%, cholesterol increases the rigidity of the Ld phase, 
meaning that a part of the molecules contributes to the stabilization also of the 
fluid phase. Moreover, changing the composition of the membrane, we were 
able to assign confidently a characteristic height value to each lipid phase. In 
this way, we allotted our experimental point on previously reported lipid phase 
diagram confirming our speculations. Finally, we characterized by GISAXS 
measurements our system. Preliminary results on supported lipid bilayers 
composed by DOPC/SM + 10 mol% cholesterol have been presented. By 
GISAXS, it was possible to calculate the height variation of the two lipid 
phases changing the humidity (from 5% to 85% and again to 5%). The results 
show a strong water effect on the Ld phase that increases its height as the 
humidity increases whereas the ordered phase is much less affected by this 
variation. This means that Ld phase, having more structural defects is much 
more available for water molecules insertion and the phenomenon is reversible. 
Water has a relevant role in the packing and order of the membrane, as 
observed by AFM topography too. The electron density map gave the 
possibility to understand better the effects on the Lo phase. The results show, as 
expected, a weak effect of the already well ordered phase with the only 
expected increase in the water layer with negligible effect on lipid structure. 
Unfortunately, the lack of order in the Ld phase at low humidity, did not allow 
the same calculations for this phase. Therefore, these preliminary results 
highlighted the potential use of this technique, in combination with AFM, in the 
precise characterization of supported lipid bilayer, which could be used to 
deepen the knowledge in this field.  
In the second part of the chapter, we presented preliminary results about the 
application of our model system in order to study the AS binding to lipid 
membrane. It is known indeed that the protein interacts with lipid cell 
membrane and synaptic vesicles membrane. Previous reports described the 
preferential binding to anionic lipids in artificial membranes and the formation 
of tubules on negatively charged lipids but many aspects are still under debate. 
For example it is known that acidic phospholipids amount in synaptic vesicles 
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is around 10-18% whereas AS binds synthetic membrane when this amount is 
around 30%. In literature, it has also been supposed a preferential interaction 
with lipid rafts but also preferential interaction with disordered phase has been 
reported. Moreover, AS binds with higher affinity small radius SUVs 
suggesting a role of membrane defects in the protein insertion. For all these 
reasons, we tried to clarify some of these aspects using our supported lipid 
membranes systems. In particular, the use of lipids with no net charge can help 
in the comprehension of lipid charge effect in the binding. Moreover, the use of 
membrane with different phases can give further indication about the presumed 
interaction with lipid rafts. First, we analyzed by real-time AFM measurements 
the binding of the protein to the lipid bilayer in liquid. What we observed was 
that AS does not bind the membrane if So phase only is present, meaning that 
probably the highly ordered structure does not allow the insertion of the protein. 
In the presence of Ld-So phase separation instead, AS binds the membrane and 
forms tubular structures. A similar but slower behavior on Ld-Lo phases has 
been observed. Moreover, a strong effect on the lipid phase separation has been 
ascertain in both cases. Preliminary GISAXS measurement, performed on Ld-Lo 
phase, confirmed AFM measurements showing an initial decrease in the height 
of the two phases. The formation of one single phase at high hydration has also 
been speculated. Due to techniques limitations, it is difficult to understand 
structural AS changes, although referring to previous literature data some 
speculations can be done. For example, the formation membrane-bound 
aggregates potentially neurotoxic could be possible in our system. The height of 
these structures is in fact compatible with the partial insertion of the protein into 
the membrane. From the other hand, it has been reported the formation of 
tubular structures upon AS binding to lipid bilayers due to the membrane 
deformation 89,91. Moreover, a possible effect on the membrane curvature and 
loss of membrane integrity has been suggested. Therefore, the decrease of the 
height of the layer, observed by both GISAXS and AFM, could be addressed to 
the insertion of the protein into the bilayer. In other words, the decrease in the 
radius of curvature of lipid vesicles reported in literature, could be translated in 
the decrease in the height of the lipid bilayer, due to the insertion of defects in 
the membrane layer that alter the integrity and the order, leading to one phase 
only. 
For these reasons, among our perspectives, we plan to complete our 
measurements by AFM and GISAXS in order to understand the parameters at 
which the formation of these tubular structures occurs, for example modulating 
   
116 
 
cholesterol concentrations. Moreover, the use of complementary techniques and 
theoretical modeling could allow a better comprehension of the phenomenon 
and the protein structural changes at the basis of the binding. 
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6. Materials and methods 
6.1 AS on gold surface 
6.1.1 Materials and instrumentation 
 
EG6-thiols ((1-mercaptoundec-11-yl)tri(ethyleneglycol), HS-(CH2)11-
(OCH2CH2)3-OH), and EG3-thiols ((1-mercaptoundec-11-
yl)hexa(ethyleneglycol), HS-(CH2)11-(OCH2CH2)6-OH), were purchased from 
Prochimia Surfaces (Poland). KCl, TRIS (2-Amino-2-hydroxymethyl-propane-
1,3-diol), TCEP (tris(2-carboxyethyl)phosphine), sodium acetate, methanol and 
ethanol (99.8% purity) were all provided by Fluka and Sigma Aldrich, (Milan, 
Italy). All the solutions were prepared in ultrapure 18.2 MΩ·cm water (Milli-Q, 
Millipore SpA, Milan, Italy), and filtered with a sterile syringe-filter (0.22 μm) 
prior to use. All other reagents were of analytical grade. All AFM experiments 
were carried out with conventional AFMs using a XE-100 (Park System, former 
PSIA, Korea) and a MFP3D Stand Alone AFM, (Asylum Research, Santa 
Barbara, CA) working in contact mode. For nanografting commercially 
available silicon cantilevers (NSC19, Mikro- Masch, Poland, nominal spring 
constant 0.6 nN/nm, tip radius <10 nm) were chosen. For CM-AFM imaging 
purposes, a soft cantilever (CSC38B, MikroMasch, Poland, nominal spring 
constant, 0.03 nN/nm, tip radius <10 nm) was used. 
 
6.1.2 Substrate and monolayer preparation 
 
An ultra-flat gold surface was prepared following the Template Stripped Gold 
(TSG) procedure described by Wagner et al 208. Briefly, a layer of gold was 
evaporated on freshly cleaved mica sheets (clear ruby muscovite, Goodfellow 
Cambridge Limited, Huntingdon, England) or on a Si(100) wafer using an 
electron beam gold evaporator. Gold films were deposited at a rate of ~0.1 nm/s 
and a chamber pressure of about 10-6 mbar until a thickness of 100 nm was 
reached. These films were fixed to Si(100) wafer pieces with a drop of SU8-100 
(MicroChem Corp., MA), and the polymer was then cured (baked 5h at 95°C, 
exposed 20 min under a 70 μW/ cm2, 462 nm UV lamp, and baked at least three 
hours at 95 °C). They were then separated at the gold–mica (or gold-Si) 
interface by peeling immediately before functionalization. This procedure made 
gold substrates with a flat surface morphology, reproducing the atomically flat 
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mica surface. Samples are then soaked in a freshly prepared 300 μM solution of 
EG6-terminated thiols in ethanol. The substrates were incubated overnight in 
the dark at room temperature. In this way, a self-assembled monolayer (SAM) 
of thiolated molecules covers the ultra-flat gold surface. AFM test 
measurements confirmed a roughness of the substrate in the range of 0.3-0.4 
nm. 
 
6.1.3 Recombinant Di-Cysteine AS expression and purification 
 
In order to remove most tags at the end of the purification process, we used 
Profinity eXact™” fusion-tag system (Bio-Rad Laboratories, Hercules, Calif.) 
which uses an immobilized subtilisin protease to carry out affinity binding and 
tag cleavage to produce Di-Cysteine AS. The human AS cDNA was isolated by 
pUC57-α-syn vector purchased by GenScript. The following primers were 
used: 5’ CGAAAGCTTTGACTTCT TGCTGCGATGTATTC ATGAAAGG 3’ 
containing nucleotides coding for Thr-Ser linker to obtain an optimal cleavage 
during the purification step, nucleotides coding for two Cys and restriction site 
for Hind III and 3’ TACCCATGGTTAGGCTTCAGGTTCGTAGTCTT 5’ 
containing the restriction site for NcoI. The α-Syn cDNA was cloned into the 
Hind III and NcoI restriction sites of the bacterial expression vector pPAL7. 
BL21(DE3) E. coli were transfected with pPAL7/Cys-α-syn plasmid, and 
expression was induced by the addition of isopropyl β-D-thiogalactopyranoside 
(IPTG). Cells were harvested, resuspended in 10 mM Tris, pH 8, 1 mM EDTA, 
1 mM PMSF (1/10 culture volume), and lysed by freezing in liquid nitrogen 
followed by thawing and probe sonication. The di-Cyst AS protein was purified 
by size-exclusion chromatography (Superdex 200 10/300 GL, Amersham 
Bioscences) with 50mM sodium phosphate buffer pH 7.4, 300 mM NaCl. After 
the collected fraction was purified by using Profinity exact resin (Bio-Rad 
Laboratories, Hercules, Calif.). The protein purified was verified by SDS PAGE 
2-15% and then lyophilized. Di-Cyst AS protein was determinated to be ca. 
97% pure by SDS-PAGE. 
 
6.1.4 Cysteine-tagged AS AFM Nanografting and imaging 
 
Nanografting experiments were performed as follows: a freshly SAM 
passivated gold substrate was rinsed with ethanol and fixed in an AFM closed 
liquid cell.  The gold surface was scratched with a worn out AFM tip to have a 
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recognition point onto the surface to facilitate finding back the nanostructures. 
The liquid cell was filled with the nanografting solution that contains 3 mM 
cysteine-tagged AS in methanol with the addition of 1 mM TCEP dissolved in 
methanol. The patches were obtained in contact mode scanning the desired area 
at high load (about 100 nN) and at a scan rate about 2 Hz. In this way local 
excange between the EG6-thiolated molecules and the protein in solution is 
promoted. During nanografting procedure, patches of about 1 μm2 (512x512 
pixels) were fabricated. 
The liquid cell was abundantly washed with 10 mM TRIS, 150 mM KCl, pH 
7.4 after the incubation time of every step of the experiments. The imaging was 
performed in the same buffer at minimum load forces (below 100pN). 
 
6.1.5 Dopamine (DA) Binding 
 
Dopamine (Sigma Aldrich) was freshly dissolved and incubated with increasing 
concentration (from 10nM to 10mM) in buffer 20 mM sodium acetate, 150 mM 
KCl pH 5.5, to minimize auto-oxidation. The differential height was used as the 
response signal and fitted to a Langmuir isotherm 209, that describes the binding 
of a ligand to a macromolecule, in Igor Pro (Wavemetrics, Inc.). The 
topographic measurements were performed after 30 minutes incubation, time 
sufficient for the diffusion and the binding of the DA. A mAb (8 nM, syn clone 
211, Sigma Aldrich) 193  was used to recognize AS patches. The antibody was 
diluted in buffer 10 mM TRIS, 150 mM KCl, pH 7.4 and incubated for 2 hours. 
 
6.1.6 Non-competitive binding 
 
Nanografted AS patches were incubated in presence of a solution of the mAb 
(syn clone 211, Sigma Aldrich) 193 8 nM, dissolved in 10 mM TRIS, 150 mM 
KCl, pH 7.4 and incubated for two hours. The topographic measurements were 
performed after 30 minutes incubation, time sufficient for the diffusion and the 
binding of the DA. The differential height was used as the response signal and 
fitted to an inverted Langmuir isotherm 209, that describes the non-competitive 
binding of a second ligand to a macromolecule, in Igor Pro (Wavemetrics, Inc.). 
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6.1.7 AS self-association 
 
Recombinant human AS histine-tagged (Sigma Aldrich) was freshly dissolved 
at 3.5 µM concentration in buffer 10 mM TRIS, 150 mM KCl, pH 7.4. AS 
nanografted patch were incubated in presence of the histidine tagged AS for 
different times. 20 µM DA was added and incubated for 30 minutes over the 
self-associated AS patches. The further addition of 3.5 µM AS in presence of 
DA for 24 hours did not increase the height of the patches. 
 
6.1.8 Images analysis 
 
For each experiment were fabricated multiple patches that contribute to the 
experiment statistic. For every patch the average height was calculated from the 
average profile and together with the standard deviation. Topographic images 
of the patches are then analyzed in term of pixel distribution (region analysis) in 
order to get the height value related to the patch at each single step of the 
experiments. The AFM instrument proprietary software (XEI, Park System, and 
MFP3D, Asylum Research) as well as free open source software, Gwyddion 
(www.gwyddion.net), were used. 
 
6.1.9 Histidine-NTA coupling 
Multiple Nanografting Assembled Monolayers (NAM) of thiol modified single 
strand DNA (ssDNA) were prepared by serial AFM-based nanografting inside a 
Self Assembled Monolayer of a Top oligo ethylene glycol terminated 
alkanethiol, ((1-mercaptoundec-11-yl)tri(ethyleneglycol), HS-(CH2)11-
(OCH2CH2)3-OH from Sigma Aldrich) on ultraflat gold surfaces following 
standard protocol reported earlier. The DNA patches were obtained promoting 
the replacement of the TOEG molecules with the oligonucleotides by scanning 
an area of 1μm x 1μm with the AFM tip applying a large force (about 100 nN) 
in presence of a solution of thiolated 24 bases ssDNA sequences (5 μM in TE 
buffer 1 M NaCl). The imaging was performed in Phosphate saline buffer 
(PBS) modified with the addition of 1M NaCl. 
The complex in solution was prepared in PBS plus 10 µM NTA-cDNA, 5 µM 
NiCl2, 5.5 µM D18 (or AS), vortexed for 30 minutes. The complex was then 
incubated on the nanografted ssDNA for 1 hour at room temperature. Finally, 
the sample was carefully washed with PBS and imaged in PBS modified. 
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6.1.10 Amino-coupling 
A 16-mercaptoesadecanoic acid SAM was preparared immerging a ultraflat 
gold substrate into a 100 µM solution of the thiol dissolved in ethanol 
overnight. After a careful wash of the surface, nanoshaving has been performed 
in ethanol following the grafting procedure described above. After that, a 
solution containing DCC 100 mM and NHS 100 mM, dissolved in Phosphate 
buffer 10 mM+ NaCl 150 mM, was mixed and incubated on the sample for 15 
minutes. After abundant wash with Tris-buffered saline (TBS) a solution 
containing 0.5 mg/mL of Potassium/sodium hyperpolarization-activated cyclic 
nucleotide-gated channel 4 (HCN4) has been incubated for 45 minutes. In this case, 
nanoshaving has been performed in TBS/ethanol 1:1. 
 
6.2 AS on lipid bilayers 
6.2.1 Materials and instrumentation 
 
18:1 (Δ9-Cis) PC (DOPC) 1,2-dioleoyl-sn-glycero-3-phosphocholine, 
Sphingomyelin (d18:1/12:0) N-(dodecanoyl)-sphing-4-enine-1-phosphocholine 
and cholesterol were purchased by Avanti polar lipids (Alabaster, USA). 
Chloroform, decane were all provided by Fluka and Sigma Aldrich, (Milan, 
Italy). All the solutions were prepared in ultrapure 18.2 MΩ·cm water (Milli-Q, 
Millipore SpA, Milan, Italy), and filtered with a sterile syringe-filter (0.22 μm) 
prior to use. 
 
6.2.2 Supported lipid bilayers preparation 
 
DOPC, SM and cholesterol has been dissolved in choloform:decane 2:1 in 
1mM concentration at various molar ratio. For AFM measurements 50 µL of 
the lipid solution has been deposited on freshly cleaved mica sheets (clear ruby 
muscovite, Goodfellow Cambridge Limited, Huntingdon, England) of around 1 
cm2 and lead for solvent evaporation in incubator (SANYO MCO-18AC 
incubator) at 30°C and 80% humidity.  
Wild-type human AS (Sigma Aldrich) 3 µM was dissolved in Hepes 10 mM and 
added to the liquid cell for AFM imaging. 
For GISAXS measurements Si wafers, after careful cleaning process (wash 
with acetone, isopropanol, and ethanol), 1 cm2, have been used as substrate for 
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the deposition of 200 µL of lipid solution, leaved in incubator and put in 
vacuum chamber overnight in order to remove solvent residues. For AS 
GISAXS experiments, after the preparation of the membrane, AS solution 
(3µM dissolved in milliQ) was incubated for 4 hours and then removed, the 
sample washed and dried before measurements 
 
6.2.3 AFM imaging 
 
All AFM images were acquired using a commercially available microscope 
(MFP-3D Stand Alone AFM from Asylum Research, Santa Barbara, CA). 
Measurements were carried out at room temperature working in dynamic 
tapping mode. For imaging, commercially available silicon cantilevers (NSC19, 
Mikro- Masch, Poland, nominal spring constant 0.6 nN/nm and Olympus 
OMLC 800 PSA-1, nominal spring costant 0.76 nN/nm,) have been chosen for 
imaging in air and liquid respectively. In both cases cantilevers were used 
working at low oscillation amplitudes with half free amplitude set-point. High-
resolution images (512 x512 pixels frames) were acquired at 0.6-1 lines/s scan 
speed. 
 
6.2.4 FMM 
 
Force modulation measurements were performed with a commercially available 
microscope (NT-MDT SolverPro AFM, Moscow, Russia) in air. 
A cantilever characterized by a resonant frequency of about 12 kHz (NSC21 A, 
Mikro- Masch, Poland, nominal spring constant 0.12 nN/nm) was used. The 
imaging was performed in the same buffer at minimum load forces (below 
100pN) and the amplitude of the sample oscillation was fixed at 0.5 V. the 
images has been recorded with a resolution of 512 x 512 lines and a scan rate of 
0.2 Hz. 
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Appendix 
 
Other nanografting applications: single cell proteomics for 
tumor biomarkers detection f 
Based upon the latest genetic and proteomic insights into cancer biology, which 
opened new avenues for novel applied clinical research, trends in oncology 
highlight that molecular characterization of the tumorigenesis process will be 
essential in tomorrow’s clinical practice both to predict prognosis and to guide 
therapy 210. Noteworthy, the promise of individualized molecular medicine, that 
is particularly relevant to oncology, where even similarly classified tumors can 
follow quite different clinical outcomes, could be realized by identifying 
molecular targets for therapy and by measuring tangible response or regression 
in clinical trials 211. 
Specific patterns of protein expression in tumors and matched normal tissues 
can now be reliably analysed using quantitative proteomic techniques. 
Nevertheless, when it comes to the analysis of small cell’s volumes (μl to pl), 
only miniaturized arrays of proteins may boost the detection of key 
biomolecules, eventually responsible for cellular-cellular or surface-cellular 
interactions 211. In fact, one of the main limits to knowledge advancement in 
oncology is the high sensitivity required to identify specific tumor (stem) cells 
protein patterns and to correlate them with cell behaviour 212,213. Such caveat 
suggests that new quantitative approaches, as the one based on nano-
immunoarrays technology, could be highly effective in enabling a precise, and 
ultimately, low cost analysis of tumor cells’ protein content (down to the few 
cells level). However nanotechnology-based approaches could be (and also are 
currently being) explored to discover, identify and quantify clinically useful 
molecular signatures for early detection, diagnosis and prognosis of several 
tumors 214–217.  
Focusing our attention to neuro-oncology, we identified the remarkable need 
for more sophisticated diagnostic tools with potential capability of 
unprecedented pathological screening and subtyping of glial tumors. These 
                                                            
f M. Ganau, A. Bosco, A. Palma, S. Corvaglia, P. Parisse, L. Fruk, A.P. Beltrami, D. Cesselli, L. 
Casalis,  G.  Scoles.  “A  DNA‐based  nano‐immunoassay  for  the  label‐free  detection  of  Glial 
Fibrillary Acidic Protein in multicell lysates”, NanoMed, submitted.  
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latter are the most common primary malignant brain tumors, and, among them, 
the most aggressive ones, namely Glioblastomas (WHO Grade IV) and 
Anaplastic Astrocytomas (WHO Grade III), present an incidence of 3.5-2.8 and 
0.3-1.2 new cases per 100.000 per year respectively 218.  
Gliomas are characterized by rapid growth, high level of cellular heterogeneity 
due to genetic alteration, and invasive behaviour. Complete microscopic 
excision followed by adjuvant radio- or chemotherapy represents the standard 
of care; nevertheless tumor recurrence generally occurs within few months due 
to the widespread neoplastic infiltration 219. In fact, primary brain tumors 
invade widely spreading single cells anywhere within the brain parenchyma, 
through infiltration of blood vessel walls, subpial glial spaces, or white matter 
tracts. These mechanisms lead to the development of tumor satellites, probably 
sustained by glial stem cells escaping resection and treatment, eventually 
serving as reservoirs for tumor recurrences. Despite continuous refinements in 
therapeutic strategies, the prognosis for patients with high-grade gliomas 
remains dismal, and less than 5% survive more than 5 years despite aggressive 
therapies 219. 
There are several challenges to overcome in the successful treatment of 
glioblastoma. Among others, these include the characteristic tumor 
heterogeneity of glioblastoma, and the possible difficulty in overcoming 
resistant cancer stem cells (CSCs) 220. In fact, despite some controversy 
concerning their exact role and characterization, CSCs are believed to play a 
crucial role in malignant glioma tumor initiation, progression, angiogenesis and 
both drug- and radio-resistance 221. Therefore, the characterization of the 
protein content of glioma CSCs can help in developing drugs specifically 
targeting this extremely rare tumor-subpopulation and may improve the 
molecular classification of brain tumors 220. As mentioned, this possibility 
would be made possible only by the development of innovative nano-immuno-
arrays. 
A systematic review of multiple independent proteomic analyses of gliomas 
published on PubMed since 2008 has demonstrated alterations of almost 100 
different proteins; among them, we have chosen the Glial Fibrillary Acidic 
Protein (GFAP), a biomarker belonging to the family of intermediate filaments 
for our proof of concept. GFAP is expressed by numerous cell types of the 
Central Nervous System (CNS), especially astrocytes and is crucial in cell’s 
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differentiation, so that only well differentiated cells retain the ability to express 
it, while the most aggressive ones lose this typical feature at a certain point in 
their dedifferentiation. GFAP is therefore functional to grade classification of 
gliomas. 
During the first period of my PhD, I performed preliminary tests about 
developed a quantitative approach to enable precise and multiplexing protein 
analysis of very small systems, down to a single or a few cells. The proof of 
concept was realized for GFAP detection. In particular, we designed specific 
nano-immunoarrays capable to detect the presence of GFAP expression in small 
volumes and envisage the possibility to integrate it to a facing array of micro-
fabricated wells (see Fig A1) hosting living astrocytes (ideally, one cell per 
micro-well). 
 
 
 
Figure A1: Nano-immuno detection platform for few cells proteomic screening. A) Cartoon 
showing the hosting of one cell per well. B) Biosensor topped well containing a single cell 
secreting a protein of interest (Antigen) C) Topographic  image of the area containing of the 
DNA-based-nano-immuno-sensors D) Cartoon showing the elements of one nanoimmuno 
sensor (patch). E) Scheme for the realization of the nanoimmunopatch. 
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To realize the nano-immunoassay for the detection of GFAP we used a 
combination of DNA barcoding, one of the leading technology for multiplexing 
bioassays and DNA Directed Immbilization (DDI) of DNA-protein conjugates. 
Using nanografting, we confined DNA molecules at the nanoscale in a 
nanoarray format, within a self-assembled monolayer (SAM) of biorepellent 
alkanethiols.  
 
Preparation of nanopatches via DDI of biotinylated antibodies and 
recognition of GFAP w/wo cell lysate 
The preparation of nano-immunoarrays was carried out with the aim to 
optimize protocols for future proteomics multiplexing analyses. As already 
mentioned, nanografting has unique capabilities for controlling and optimize 
density 146 and conformation 142 of patterned biomolecules at the nanometer 
scale. Moreover, the intrinsic characteristics of DDI, such as high efficiency of 
adsorption, site-selectivity and reversibility, allow for selective immobilization 
of a specific protein of interest on the generated DNA patterns using 
semisynthetic protein-DNA conjugates 145. 
The suitability of our nano-immunoarrays to selectively recognize the protein of 
interest not only in presence of recombinant GFAP alone but also in the whole 
cell extracts, which contains several different proteins potentially prone to bind 
unspecifically over the NAMs and/or the surrounding SAM, was finally tested 
by incubating nanopatches with 100μl of cell lysate (obtained by lysing 106 
glioblastoma U87 cells in 100μl of RIPA buffer) with and without GFAP at a 
known concentration of 40nM. 
The three preliminary steps (grafting of ssDNA, hybridization of DNA-STV 
conjugate, immobilization of biotinylated GFAP Ab) needed to realize the 
nano-immunoarrays above described, along with the subsequent immobilization 
of GFAP in standard conditions and in the cell lysate were confirmed by 
topographic analysis performed by AFM. 
On average the DNA’s NAM’s height increased of 7.5±2.5 nm upon DNA-STV 
conjugate immobilization (n=18, p≪0.01) and 6.5±2.3 nm after GFAP Abs 
(n=17, p≪0.01). This progressive NAMs’ height increase indicates that 
stepwise addition of the ligands (first DNA-STV, then GFAP Ab) occurs. 
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The roughness of both NAMs and SAMs, as showed in Table A1, did not 
change significantly before and after incubation with a GFAP-free cell lysate 
(p≪0.01 in all comparison) meaning that the biomolecules contained in the 
lysate do not attach to the surface of the nanopatches  and onto the surrounding 
biorepellent SAM. 
 
SAM Before incubation (Time 0) 
After incubation 
(1 h)  
cDNA+STV 0.2 ± 0.01 nm 0.2 ± 0.01 nm 
cDNA+GFAP Ab 0.28 ± 0.01 nm 0.28 ± 0.01 nm 
NAM Before incubation       (Time 0) 
After incubation 
      (1 h)  
cDNA+STV 1.3 ± 0.5 nm 1.3 ± 0.7 nm 
cDNA+GFAP Ab 1.9 ± 0.5 nm 1.9 ± 0.8 nm 
 
Table A1: Roughness Analysis of the nanopatches before and after incubation with the cell 
lysate 
 
In fact, the analysis of the topographic images showed that only in the presence 
of GFAP, significant increment (p<0.05) in the height of the nanopatches 
(Table A2, Fig. A2) could be observed. 
 
 
Figure A2: (A) Height profiles of a nanopatch before (black) and after (red) incubation with a 
BB solution containing 40 nM of recombinant GFAP; (B) Height profile of a patch before 
(black) and after (red) incubation with a cell lysate containing 40 nM of recombinant GFAP. 
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Table A2: Height variation of nanopatches topped with GFAP antibodies after 1 hour 
incubation with BB solution and cell lysate w/wo recombinant GFAP (40 nM). BB=Blocking 
Buffer. 
 
A 3D image of the nanopatches after the recognition of GFAP in cell lysate is 
performed, also confirms the absence of non-specifically bound proteins to the 
area surrounding each NAM (Figure A3).  
 
 
Figure A3: AFM topographic 3D representation of successful recognition and immobilization 
of GFAP added to cell lysate (white patches) and the absence of non-specific binding of protein 
cell extract proteins (surrounding area).  
 
Incubation with BB solution Height variation (nm)  
Without GFAP -0.8 ± 0.9 nm p=0.13, N=11 
With GFAP (40nM) 3.9 ± 1.1 nm p=0.02, N=7* 
Incubation with Cell Lysate Height variation (nm)  
Without GFAP 0.4 ± 0.5 nm p=0.14, N=6 
With GFAP (40nM) 2.9 ± 1.5 nm p=0.03, N=4 * 
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The Elisa benchmark 
Once GFAP detection within a cell lysate was optimized, we wanted to 
investigate whether it is possible to quantitatively determine the concentration 
of GFAP in the sample. For this reason we obtained the affinity calibration 
curve for our nanobiosensor assay by measuring the variation in height of the 
nanopatches functionalized with the antibodies for GFAP after the incubation 
with blocking buffer containing a pre-determined concentration of GFAP 
ranging from 200 pM to 100 nM. As shown in Fig. A34, the changes in height 
detected for increase of GFAP concentration showed a sigmoidal behaviour, as 
expected for the binding of an antigen to an antibody. In order to quantitatively 
describe the recognition of GFAP via our nanobiosensor assay, we used the Hill 
equation. From the fit, we obtained a dissociation constant in the nanomolar 
range (Kd= 6.6±3.8 nM) and a slightly cooperative effect (n >1). However, the 
large error in the Hill coefficient could mask the fact that the system also has a 
negative cooperative effect meaning that once an antigen binds to an Antibody 
(Ab), then the affinity of the Ab for other antigens decreases. In fact, in case of 
our biosensor, we expect that the steric hindrance between proximal Ab on the 
patches could contribute to a decrease of cooperativity. 
 
Figure A4: Binding curves obtained from the height variation (a) and absorbance obtained 
using ELISA (b) vs GFAP concentration. Experimental data are shown in black and the fitting 
curves obtained by Hill equation in red. Values of hmin=0.78±0.28 nm, hmax=5.07±0.75 nm, 
n=1.43±0.82 and KD=6.6±3.8 nM were obtained for nanoassay and Amin=0.00 ±0.01, 
Amax=1.55±0.10, n=1.51±0.26 and KD=8.30±1.04 nM for ELISA assay.   
 
In order to compare the binding affinity curve of our nanobiosensor assay with 
a standard technique, we also obtained an ELISA assay for GFAP 
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measurements using the same antibodies and we analogously fitted the values 
of absorbance with Hill equation. The value of n=1.51±0.26 indicated that a 
cooperative effect of the recognition event is present and a dissociation constant 
equal to Kd =8.30±1.04 nM is perfectly in agreement with the value found for 
the nanosensor assay showing a potential of our nanodevice to be an alternative 
to ELISA. 
 
Microwell development 
In parallel to the development of the quantitative nanoimmunoassay, I focused 
on the development of a microwell array able to host single o few cells.  
Microwell fabrication 
Arrays of microwells with different geometries (lateral dimension 50-100 µm, 
depth 25 µm) were produced in three steps. First, a silicon-SU8 master was 
produced by standard photolithography obtaining a pillar like structure. Second, 
a polydimethilsiloxane (PDMS, Sylgard 184, Silicon elastomer, Dow Corning) 
mold was created casting a drop of PDMS (1:10 curing agent to prepolymer, as 
suggested by manufacturer) on the master and treated at 60°C for 1 hour to 
promote the polymerization. Third, the membrane was peeled off and stuck on a 
glass slide. 
The main advantage of the PDMS substrates is that they allow to produce 
microwells of the desired diameters, according to the specific dimension of the 
hosted cells.  For astrocyte analysis, our microwells were fabricated with a size 
of 100 µm in diameter x 25 µm in depth.  
 
Surface functionalization 
PDMS surface alone is not able to enhance the adhesion and grow of neurons as 
observed experimentally. For this reason, a functionalization with adhesion 
molecules such as polyornithine or fibronectine was needed (Fig. A5). 
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Figure A5. Hyppocampal cell colture requires PDMS treatment with polyornithine. PDMS 
without any treatment is not suitable for cell grouth, while functionalization with polyornithine 
show good cell adhesion and grow after 5 days incubation. The image shows fixed cells stained 
with Coomassie blue. 
 
In order to permit the neuron adhesion and growth on PDMS surface of the 
microwells bottom only, we functionalized them with an inverted microcontact 
printing method (Fig. A6). First of all the PDMS membrane was exposed to air 
plasma for 5 minutes to create negative charges promoting hydrophilicity of the 
surface and the absorption of positively charged molecule. A polyornithine 
solution (0.01% polyornithine plus 5% Lucifer yellow for the visualization, 
Sigma Aldrich) was incubated on the surface for 1 hour and then dried under a 
nitrogen stream. The excess of polyornithine outside each microwell was 
removed inverting immediately the sample on a glass slide overnight and a 
weight was placed on top during the stamping period. 
 
 
Figure A6: Functionalization of PDMS microwells with polyornithine stained in green by 
lucifer yellow. Scalebar: 50 μm 
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Cell viability and grow 
 
In order to test the biocompatibility of our micropatterned PDMS wells, we 
decided to grow a human glioblastoma commercial cell line (U251-MG) as well 
as CD133 positive stem cells isolated from glioblastoma biopsies on a 
fibronectin-coated PDMS membrane. Cells entered into the PDMS microwells 
and adhered to the floor, where they survived for few days. Both U251 and 
glioma-isolated stem cells express high levels of GFAP, so their presence and 
viability within the microwells was revealed and confirmed by anti-GFAP 
staining (Fig A7). 
 
 
Figure A7:  Glioblastoma cells cultured into functionalized PDMS microwells and stained for 
GFAP. Tumoral cells isolated from a glioblastoma biopsy (left) and U251 cells (right) were 
seeded on a micropatterned PDMS membrane. GFAP expression was revealed by 
immunofluorescence (red fluorescence) and nuclei were depicted by the blue fluorescence of 
the DAPI staining. Fluorescence and phase contrast images were overlaid by using Adobe 
Photoshop software.  
In conclusion, we demonstrated the feasibility of our approach, that combines 
nanotechnological principles such as nanografting and DDI and capitalizes on 
the chemical robustness of DNA oligomer strands and on the reliable assembly 
of DNA labeled molecular binders via complementary hybridization 222, to 
produce nano-immunoarrays for biomarkers detection. Our DNA 
immunoassays are miniaturized reaching an active area of about 1 μm2 per spot. 
Noteworthy, this strategy for realizing nano-immunoarrays is particularly 
advantageous in terms of multiplexing analysis since the limiting factor for the 
number of protein to be tested is only the number of different DNA strands and 
protein-binding antibody used. 
The results herein discussed represent an initial step to test the sensitivity and 
specificity of nano-immunoarrays designed for the detection of a pivotal glioma  
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biomarker, GFAP.  We are at present working to push DDI strategy for the 
concomitant detection of several proteins of interest, making this technique a 
valid alternative for the current benchmark of ELISA-based proteomics.  
Although further studies are warranted to better characterize this technique of 
label-free nano-immuno detection, the promising results obtained in a cell 
lysate confirm the suitability of this diagnostic method to effectively work in a 
complex environment without being influenced by the unspecific bindings of 
many elements included in the cell’s proteome.  
On the other side, we produced PDMS microwell arrays for hosting cells, to 
eventually be sorted via standard biochemical techniques, and demonstrated cell 
viability,  upon properly functionalizing the bottom of the wells.  
As a last step, we are working at aligning the microwells array onto the nano-
immunoarray, engineered with the same repetition of active nano-areas in 
correspondence of each well, to obtain biomarkers profiling from the 
secretome/lysate of a pool of single sorted cells.   
Another potential application of our device can be the study of protein 
expression of cells induced by the interaction with the substrate. It is known 
indeed that the substrate can modulate the cell shape, proliferation, 
differentiation or induce cell apoptosis. I did obtain some preliminary results 
about the growth of cells on PDMS substrates with different stiffness. In 
particular, I observed different levels of differentiation of adipose stem cells 
grown on PDMS with different Young’s modulus (data not shown). The 
morphological variation due to substrates’ stiffness deserve for sure further 
investigations. I plan to continue working along this direction, since I am 
confident of the potential implications in tissue engineering and regenerative 
medicine. 
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